Poisons Standard March 2016 (Cth)

POISONS STANDARD MARCH 2016

I, ANTHONY GILL, a delegate of the Secretary to the Department of Health for the purposes of paragraph 52D(2)(b) of the Therapeutic Goods Act 1989 (the Act) and acting in accordance with the Secretary’s power under that paragraph of the Act, prepare this new Poisons Standard, in substitution for the current Poisons Standard.

(Signed by)

ANTHONY GILL

Delegate of the Secretary to the Department of Health

Dated this 24^th February 2016

1.         Citation

This instrument is the Poisons Standard March 2016.

2.         The New Poisons Standard

The Poisons Standard March 2016 consists of the Standard for the Uniform Scheduling of Medicines and Poisons No. 11 (the SUSMP 11) as set out in Schedule 1.

3.         Commencement

The Poisons Standard March 2016 commences on 1 March 2016.

Schedule 1-Standard for the Uniform Scheduling of Medicines and Poisons No. 11

STANDARD FOR THE UNIFORM SCHEDULING OF MEDICINES AND POISONS

No. 11

March 2016

Reasons for scheduling delegates’ final decisions can be accessed from the TGA website, at  

Further inquiries in relation to this document should be directed to:

The Secretary
Chemicals Scheduling Secretariat (MDP88)
Office of Chemical Safety
Department of Health
GPO Box 9848
CANBERRA ACT 2601

or by email to [email protected]

The Secretary
Medicines Scheduling Secretariat (MD122)
Communications and Secretariat
Therapeutic Goods Administration
PO Box 100
WODEN ACT 2606

or by email to [email protected]

Media Liaison Unit
Australian Government Department of Health

Table of Contents

INTRODUCTION

CLASSIFICATION

PRINCIPLES OF SCHEDULING

READING THE SCHEDULES

AVAILABILITY OF POISONS

PREPARATIONS CONTAINING POISONS LISTED IN TWO OR MORE SCHEDULES

PART 1

INTERPRETATION

PART 2

CONTROL ON MEDICINES AND POISONS

SECTION ONE     LABELS

SECTION TWO    CONTAINERS

SECTION THREE    STORAGE

SECTION FOUR  DISPOSAL

SECTION FIVE    RECORD KEEPING

SECTION SIX    SALE,  SUPPLY, POSSESSION, or USE

SECTION SEVEN/Appendix I   PAINT OR TINTERS

PART 3

MISCELLANEOUS REGULATIONS

SECTION ONE    ADVERTISING

SECTION TWO    SALE OR SUPPLY

SECTION THREE    STORAGE

PART 4

THE SCHEDULES

SCHEDULE 1

SCHEDULE 2

SCHEDULE 3

SCHEDULE 4

SCHEDULE 5

SCHEDULE 6

SCHEDULE 7

SCHEDULE 8

SCHEDULE 9

SCHEDULE 10/APPENDIX C

PART 5

THE APPENDICES

APPENDIX A – GENERAL EXEMPTIONS

APPENDIX B – SUBSTANCES CONSIDERED NOT TO REQUIRE CONTROL BY SCHEDULING

APPENDIX C (see SCHEDULE 10)

APPENDIX D – ADDITIONAL CONTROLS ON POSSESSION OR SUPPLY OF POISONS INCLUDED IN SCHEDULE 4 OR 8

APPENDIX E – FIRST AID INSTRUCTIONS FOR POISONS

APPENDIX F – WARNING STATEMENTS AND GENERAL SAFETY DIRECTIONS FOR POISONS

APPENDIX G – DILUTE PREPARATIONS

APPENDIX H – SCHEDULE 3 POISONS PERMITTED TO BE ADVERTISED

APPENDIX I

APPENDIX J – CONDITIONS FOR AVAILABILITY AND USE OF SCHEDULE 7 POISONS

APPENDIX K –  DRUGS REQUIRED TO BE LABELLED WITH A SEDATION WARNING

APPENDIX L – REQUIREMENTS FOR DISPENSING LABELS FOR HUMAN AND VETERINARY MEDICINES

INDEX

INTRODUCTION

The Poisons Standard March 2016, which, under section 2 above consists of the Standard for the Uniform Scheduling of Medicines and Poisons (the Standard, or the SUSMP), is made under paragraph 52D(2)(b) of the Therapeutic Goods Act 1989, and is a compilation of decisions made under section 52D of the same Act.  The SUSMP should be read in conjunction with the Scheduling Policy Framework (SPF) of the Australian Health Ministers' Advisory Council.  Further information on the scheduling amendments and the SPF can be accessed at Refer to Part 1, Interpretation, on page 2 below for definitions of specific terms used in this document including “medicine” and “poison” (noting that the definition of poison includes medicine).

The SUSMP serves two key purposes.

Firstly, the SUSMP contains the decisions of the Secretary of the Department of Health or the Secretary's delegates regarding the classification of poisons into Schedules, as recommendations to Australian States and Territories.  The scheduling classification sets the level of control on the availability of poisons.  The scheduling of poisons is implemented through relevant State and Territory legislation.  Certain advertising, labelling and packaging requirements may also be a consequence of scheduling, but are the subject of other Commonwealth registration schemes.

Secondly, the SUSMP includes provisions for labelling, containers, storage, disposal, record-keeping, sale, supply and possession of poisons in general which are intended to be adopted for use in each jurisdiction of Australia.  Other government agencies may also impose controls on certain products, for example cosmetics.

The requirements for labelling and containers in the SUSMP are intended to integrate with existing legislative instruments for labelling and containers.  Advertising, labelling and packaging of therapeutic goods and agricultural and veterinary chemicals are also dealt with through the respective product registration schemes provided for in Commonwealth legislation. 

Poisons which are packed and sold solely for industrial, manufacturing, laboratory or dispensary use are exempt from all labelling requirements included in the SUSMP as they are covered by Safe Work Australia's National Code of Practice for the Labelling of Workplace Substances [NOHSC: 2012(1994)].  Note, however that this exemption does not extend to controls on supply of these poisons.

The SUSMP is presented with a view to promoting uniform:

• scheduling of poisons throughout Australia;

• signal headings on labels for poisons throughout Australia;

• labelling and packaging requirements for poisons throughout Australia;

• additional controls on the availability and use of poisons in Australia.

The various Commonwealth Acts, legislative instruments and other documents which integrate with the SUSMP include:

• the Agricultural and Veterinary Chemicals Code Act 1994

• the Agricultural and Veterinary Chemicals Code Regulations 1995

• the Therapeutic Goods Act 1989

• Therapeutic Goods Order 69 – General requirements for labels for medicines

• Therapeutic Goods Order 80 – Child-Resistant Packaging Requirements for Medicines

• the Required Advisory Statements for Medicine Labels (RASML).

CLASSIFICATION

Poisons are classified according to the Schedules in which they are included.  The following is a general description of the Schedules.  For the legal definitions, however, it is necessary to check with each relevant State or Territory authority.

Schedule 1.	This Schedule is intentionally blank.
Schedule 2.	Pharmacy Medicine – Substances, the safe use of which may require advice from a pharmacist and which should be available from a pharmacy or, where a pharmacy service is not available, from a licensed person.
Schedule 3.	Pharmacist Only Medicine – Substances, the safe use of which requires professional advice but which should be available to the public from a pharmacist without a prescription.
Schedule 4.	Prescription Only Medicine, or Prescription Animal Remedy – Substances, the use or supply of which should be by or on the order of persons permitted by State or Territory legislation to prescribe and should be available from a pharmacist on prescription.
Schedule 5.	Caution – Substances with a low potential for causing harm, the extent of which can be reduced through the use of appropriate packaging with simple warnings and safety directions on the label.
Schedule 6.	Poison – Substances with a moderate potential for causing harm, the extent of which can be reduced through the use of distinctive packaging with strong warnings and safety directions on the label.
Schedule 7.	Dangerous Poison – Substances with a high potential for causing harm at low exposure and which require special precautions during manufacture, handling or use.  These poisons should be available only to specialised or authorised users who have the skills necessary to handle them safely.  Special regulations restricting their availability, possession, storage or use may apply.
Schedule 8.	Controlled Drug – Substances which should be available for use but require restriction of manufacture, supply, distribution, possession and use to reduce abuse, misuse and physical or psychological dependence.
Schedule 9.	Prohibited Substance – Substances which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities.
Schedule 10/ Appendix C.	Substances of such danger to health as to warrant prohibition of sale, supply and use - Substances which are prohibited for the purpose or purposes listed for each poison.

PRINCIPLES OF SCHEDULING

Poisons are not scheduled on the basis of a universal scale of toxicity.  Although toxicity is one of the factors considered, and is itself a complex of factors, the decision to include a substance in a particular Schedule also takes into account many other criteria such as the purpose of use, potential for abuse, safety in use and the need for the substance.

This Standard lists poisons in ten Schedules according to the degree of control recommended to be exercised over their availability to the public.

Poisons for therapeutic use (medicines) are mostly included in Schedules 2, 3, 4 and 8 with progression through these Schedules signifying increasingly restrictive regulatory controls.

For some medicines and agricultural, domestic and industrial poisons, Schedules 5, 6 and 7 represent increasingly stricter container and labelling requirements with special regulatory controls over the availability of the poisons listed in Schedule 7.  Products for domestic use must not include poisons listed in Schedule 7.

Schedule 9 contains substances that should be available only for teaching, training, medical or scientific research including clinical trials conducted with the approval of Commonwealth and/or State and Territory health authorities.  Although appearing as a Schedule in this Standard, the method by which it is implemented in the States and Territories may vary.

Schedule 10/Appendix C contains a list of substances or preparations, the sale, supply or use of which should be prohibited because of their known dangerous properties. 

Substances in products which have been considered for scheduling, but have been exempted from this Standard, may be listed in either Appendix A (general exemptions) or Appendix B (substances considered not to require control by scheduling).

READING THE SCHEDULES

Schedule entries have been designed to be as simple as possible while retaining readability, legal integrity and as much freedom from ambiguity and contradiction as possible.  As a result, they are expressed in a number of ways, though this number has been kept to a minimum.  It is necessary to keep this variety of expression in mind when searching or interpreting Schedule entries.

Firstly, poisons are scheduled individually using their approved names wherever practicable although exceptions are necessary in some cases.  Some of those are mentioned overleaf.  Older group entries are revised and replaced by individual entries as time permits, although in some of these cases a group term has also been retained to deal with any members of the group or class that may have escaped attention but should be scheduled.

Secondly, Schedule entries have been expressed in either positive or negative terms and care must be taken to distinguish between the two different forms of expression. Thus, selenium is in Schedule 6 only when one of the clauses in this Schedule entry applies, while fluorides are in Schedule 6 unless one of the exempting clauses applies.

Where exceptions are included in an entry, these have been emphasised by printing the word “except” in bold type.

Where the Schedule entries for a poison make a specific exclusion or exemption, the requirements of this Standard do not apply to that poison within the constraints of that exclusion or exemption although controls under other legislation, such as pesticide registration, may apply.

Where a Schedule entry for a poison requires a specific statement to be included on a label as a condition for a product to qualify for an exemption (‘reverse scheduling’), then in cases where it is impracticable for a supplier to use the exact wording of such a statement, its wording may be varied provided that the full intent and meaning of the statement is not changed.

Where a poison has been included in more than one Schedule, the principal entry, where practicable, has been included in the most restrictive Schedule with references to the other Schedule(s) involved.

It is important to remember that a Schedule entry includes preparations containing the poison in any concentration and all salts and derivatives of the poison unless it specifically states otherwise. (See Part 1, Interpretation, subparagraph 1(2)).

It is important to note that a substance is not classed as a derivative on the basis of a single, prescriptive set of criteria.  Classification of a substance as a derivative of a scheduled poison relies on a balanced consideration of factors to decide if a substance has a similar nature (e.g. structurally, pharmacologically, and toxicologically) to a scheduled poison or is readily converted (either physically or chemically) to a scheduled poison.  However, a substance is only considered a derivative of a scheduled poison if it is not individually listed elsewhere in the Schedules, or captured by a more restrictive group or class entry.  Additionally, some entries specifically exclude derivatives.  Once a substance is determined to be a derivative of a scheduled poison, the same scheduling requirements as the scheduled poison, including limits on access, supply and availability, will apply.

Finally, when using this Standard to determine the scheduling status of a poison, it may be necessary to search each relevant Schedule as well as Appendices A, B and the Index.  In this process, if the poison is not found under its “approved name” it may be shown under a group term such as:

Group	Example
the parent acid of salts	“oxalic acid” to find sodium oxalate
the radical of a salt	“chromates” to find potassium chromate
the element	“arsenic” to find arsenic trioxide
a chemical group with similar toxicological or pharmacological activity	“hydrocarbons, liquid” to find kerosene
a pharmacological group	“anabolic steroidal agents” to find “androsterone”

AVAILABILITY OF POISONS

The purpose of classification is to group substances into Schedules that require similar regulatory controls over their availability.

These Schedules have been developed over a long period and contain poisons that may be obsolete for various reasons.  Also, as part of the move to harmonise the Australian and New Zealand classifications, many substances have been added to the Schedules for that purpose, irrespective of their availability in either country.

Inclusion of a poison in a Schedule indicates the degree of control required if it is marketed.  It does not indicate:

• that the poison is available; nor

• that is has been approved or is efficacious for any use that may be specified in a Schedule; nor

• does it negate any obligation for registration of a therapeutic good, or agricultural or veterinary chemical product containing that poison.

PREPARATIONS CONTAINING POISONS LISTED IN TWO OR MORE SCHEDULES

If a preparation contains two or more poisons, the provisions relating to each of the Schedules in which those poisons are included apply.

Where it is not possible to comply both with a provision relating to one of those Schedules and with a provision relating to another of those Schedules, the provision of the more restrictive Schedule applies, unless a contrary intention is indicated in the Schedules or relevant legislation.

The Schedules listed in order of greatest to least restriction on access and availability are 9, 10, 8, 4, 7, 3, 2, 6, 5.

Schedule 1 is not currently in use.

Some substances in certain circumstances are also subject to exemptions or additional restrictions as described in the Appendices of this Standard.  The table below summarises the purpose of each of the Appendices and the controls imposed on substances included in them.

Appendix	Title	Purpose/ controls imposed
Appendix A	General exemptions	List of classes of products or uses exempted from this Standard.
Appendix B	Substances considered not to require control by scheduling	List of poisons exempted from scheduling.
Appendix C	Appendix is intentionally left blank
Appendix D	Additional controls on possession or supply of poisons included in Schedule 4 or 8	List of poisons included in Schedule 4 or 8 where additional specified controls apply on possession or supply.
Appendix E	First aid instructions for poisons	First aid instructions for poisons (other than agricultural and veterinary chemicals and chemicals packed and sold solely for industrial, dispensary, manufacturing or laboratory use).
Appendix F	Warning statements and general safety directions for poisons	Warning statements and general safety directions for poisons (other than human medicines, agricultural and veterinary chemicals and chemicals packed and sold solely for industrial, dispensary, manufacturing or laboratory use).
Appendix G	Dilute preparations	Concentration cut-offs for specified poisons, below which the requirements of the Standard do not apply
Appendix H	Schedule 3 medicines permitted to be advertised	List of medicines included in Schedule 3 that are permitted to be advertised to the public.
Appendix I	Appendix is intentionally left blank
Appendix J	Conditions for availability and use of Schedule 7 poisons	List of poisons included in Schedule 7 where additional specified conditions apply to their availability and use.
Appendix K	Human medicines required to be labelled with a sedation warning	List of human medicines required to be labelled with a warning regarding their sedation potential.
Appendix L	Requirements for dispensing labels for medicines	Requirements applying to labels attached to medicines at the time of dispensing.

PART 1

INTERPRETATION

1.    (1) In this Standard, unless the contrary intention appears —

“Agricultural chemical” means a substance that is represented, imported, manufactured, supplied or used as a means of directly or indirectly:

a)   destroying, stupefying, repelling, inhibiting the feeding of, or preventing infestation by or attacks of, any pest in relation to a plant, a place or a thing;

b)   destroying a plant;

c)   modifying the physiology of a plant or pest so as to alter its natural development, productivity, quality or reproductive capacity;

d)   modifying an effect of another agricultural chemical;

e)   attracting a pest for the purpose of destroying it; or

f)    any active ingredient included in a product declared by regulation under the Agricultural and Veterinary Chemicals Code Act 1994 to be an agricultural chemical product;

but does not include:

g)   a veterinary chemical.

“Agricultural chemical product” has the meaning defined in the Agricultural and Veterinary Chemicals Code Act 1994.

“Animal” means any animal (other than a human being), whether vertebrate or not, and whether a food producing species or not, and includes mammals, birds, bees, reptiles, amphibians, fish, crustaceans and molluscs.

“Animal feed premix” means a concentrated preparation, containing one or more poisons, for mixing with food ingredients to produce a bulk feed for a group of animals (including fish or birds), but does not include a preparation for mixing with an individual animal’s food.

“Appropriate authority” means:

a)   in the Australian Capital Territory, ACT Government Health Directorate;

b)   for the purpose of providing an exemption from all or part of Section 1.1 to Section 1.5.3 in Part 2 of this Standard by the Australian Pesticides and Veterinary Medicines Authority, the Chief Executive Officer or their delegate;

c)   in New South Wales, the Director-General of the NSW Ministry of Health;

d)   in the Northern Territory, the Chief Health Officer of the Department of Health;

e)   in Queensland, the Chief Executive of Queensland Health;

f)    in South Australia, the Chief Executive of the Department for Health and Ageing;

g)   in Tasmania, the Secretary of the Department of Health and Human Services;

h)   for the purpose of providing an exemption from all or part of Section 1.1 to Section 1.5.3 of this Standard by the Therapeutic Goods Administration, the National Manager or their delegate;

i)    in Victoria, the Secretary to the Department of Health;

j)    in Western Australia, the Chief Executive Officer of the Department of Health.

“Approved name” means:

a)   in relation to a poison that is for human therapeutic use, the name approved for use by the Therapeutic Goods Administration;

b)   in relation to a poison that is for animal or agricultural use, the name approved for use by the Australian Pesticides and Veterinary Medicines Authority;

c)   in relation to all other poisons:

i)the name used in an entry in these Schedules; or, if no such name is given,

ii)the English name recommended by Standards Australia as the common name for the poison; or, if no such name is given,

iii)the English name given to the poison by the International Organization for Standardization; or, if no such name is given,

iv)the English name given to the poison by the British Standards Institution; or, if no such name is given,

v)the name that would comply with the requirements of part (a) or (b) of this definition, or, if no such name is given,

vi)the English name given to the poison by the European Committee for Standardization (CEN); or, if no such name is given,

vii)the international non-proprietary name recommended for the poison by the World Health Organization; or, if no such name is given,

viii)the International Nomenclature Cosmetic Ingredient name for the poison listed in the International Cosmetic Ingredient Dictionary & Handbook published by the Personal Care Products Council of America; or, if no such name is given,

ix)the accepted scientific name or the name descriptive of the true nature and origin of the poison.

“Australian Code for the Transport of Dangerous Goods by Road and Rail” means the seventh edition of the document of that name.

“Authorised prescriber” means a registered medical, dental or veterinary practitioner or such other person authorised by the appropriate authority.

“Blood” means whole blood extracted from human donors.

“Blood components” means therapeutic components that have been manufactured from blood (including red cells, white cells, stem cells, platelets and plasma), except for products derived through fractionation of plasma.

“Child-resistant closure” means:

a)   a closure that complies with the requirements for a child-resistant closure in the Australian Standard AS 1928-2007 entitled Child-resistant packaging – Requirements and testing procedures for reclosable packages (ISO 8317:2003, MOD);

b) a closure approved by an order made under subsection 10(3) of the Commonwealth Therapeutic Goods Act 1989; or

c)   in the case of a can fitted with a press-on lid, a lid of the design known as “double tight” or “triple tight”.

See also "Non-access packaging”.

“Child-resistant packaging” means packaging that:

a)   complies with the requirements of the Australian Standard AS 1928-2007 entitled Child resistant packaging – Requirements and testing procedures for reclosable packages (ISO 8317:2003, MOD);

b)   is reclosable and complies with the requirements of at least one of the following Standards:

i)the International Organization for Standardization Standard ISO 8317:2003 entitled Child-resistant packaging – Requirements and testing procedures for reclosable packages;

ii)the British Standards Institution Standard BS EN ISO 8317:2004 entitled Child-resistant packaging.  Requirements and testing procedures for reclosable packages;

iii)the Canadian Standards Association Standard CSA Z76.1-06 entitled Reclosable Child-Resistant Packages;

iv)the United States Code of Federal Regulations, Title 16, Section 1700.15, entitled Poison prevention packaging standards and Section 1700.20, entitled Testing procedure for special packaging;

c) is approved as child-resistant by any order made under subsection 10(3) of the Commonwealth Therapeutic Goods Act 1989; or

d)   is in the form of blister or strip packaging in which a unit of use is individually protected until the time of release and that complies with Section 3 (Requirements for non-reclosable packages) of Australian Standard AS 1928-2001 entitled Child-resistant packages.

See also "Non-access packaging".

“Compounded” in relation to a substance means combined with one or more other therapeutically active substances in such a way that it cannot be separated from them by simple dissolution or other simple physical means.

“Cosmetic” means:

a)   a substance or preparation intended for placement in contact with any external part of the human body, including:

i)the mucous membranes of the oral cavity; and

ii)the teeth;

with a view to:

iii)altering the odours of the body; or

iv)changing its appearance; or

v)cleansing it; or

vi)maintaining it in good condition; or

vii)perfuming it; or

viii)protecting it.

“Debitterised neem seed oil” means highly purified oil from the neem seed containing only fatty acids and glycerides of fatty acids.

“Dermal use” means application to the skin primarily for localised effect.

“Designated solvent” means the following:

acetone

dimethylformamide

N-(N-dodecyl)-2-pyrrolidone

hydrocarbons, liquid

methanol when included in Schedule 5

methyl ethyl ketone

methyl isoamyl ketone

methyl isobutyl ketone

N-methyl-2-pyrrolidone

N-(N-octyl)-2- pyrrolidone

phenyl methyl ketone

styrene

tetrachloroethylene

1,1,1-trichloroethane

"Dispensing label” means the label attached to the immediate container of a substance for therapeutic use at the time of dispensing.

“Distributor” means a person who imports, sells or otherwise supplies a poison.

“Divided preparation” means a preparation manufactured and packed as discrete pre-measured dosage units prior to sale or supply, and includes tablets, capsules, cachets, single dose powders or single dose sachets of powders or granules.

“Dosage unit” means an individual dose of a poison for therapeutic use and includes a tablet, capsule, cachet, single dose powder or single dose sachet of powders or granules.

“Drug” means a poison intended for human or animal therapeutic use.

“Essential oils” means products obtained from natural raw materials either by distillation with water or steam or from the epicarp of citrus fruits by a mechanical process, or by dry distillation.  For scheduling purposes it also means:

a)   oils of equivalent composition derived through synthetic means; or

b)   prepared mixtures of oils of equivalent composition comprising a mixture of synthetic and natural components.

“External” in relation to the use of a poison means application in the ears, eyes or nose or to a body surface other than in the mouth, rectum, vagina, urethra or other body orifice.

“First Group Paint” means a paint containing the specified proportion of any substance in the First Group to Part 2 Section 7 of this Standard.

“Free formaldehyde” includes all hydrated and non-hydrated formaldehyde present in aqueous solution, including methylene glycol and formaldehyde released from formaldehyde donors.

“Graphic material” means the material which is to be deposited on another material by a graphic instrument during writing, drawing or marking and includes cores of pencils, school pastels or crayons, blackboard chalks, finger or showcard colours, poster paints and watercolour blocks.

“Hawking” means to sell or supply (including peddle or distribute or cause to be distributed) in a public place.

“Height” in relation to letters used for words, expressions or statements on labels means the height of capital letters or lower case letters having an ascender or a descender.

“Hemp seed oil” means the oil obtained by cold expression from the ripened fruits (seeds) of Cannabis sativa.

“Immediate container” includes all forms of containers in which a poison is directly packed but does not include any such container intended for consumption or any immediate wrapper.

“Immediate wrapper” means metal foil, plastic foil, waxed paper, or any other such material not intended for consumption, when used as the first wrapper for a dosage unit or dressing.

“Internal use” means administration:

a)   orally, except for topical effect in the mouth; or

b)   for absorption and the production of a systemic effect;

i)by way of a body orifice other than the mouth; or

ii)parenterally, other than by application to unbroken skin.

“Label” means:

a)   a written statement on a container of a poison; and

b)   in relation to a therapeutic good, includes a display of printed information about the product:

i)on, or attached to, the good;

ii)on, or attached to, a container or primary pack in which the good is supplied; or

iii)supplied with such a container or pack.

“Main label” means, where there are two or more labels on a container or a label is divided into two or more portions:

a)   the part of a label that is most likely to be displayed, presented, shown, or examined under ordinary or customary conditions of display; and

b)   where there are two or more labels or two or more portions of a single label – that label or portion of the label where the product name is more or most conspicuously shown; or

c)   where the product name is equally conspicuous on two or more labels or portions of a label – each such label or portion.

“Manufacturer” means a person who manufactures, produces, or packs a poison.

“Measure pack” means a sealed container which contains a measured quantity of poison for use on one occasion as a pesticide or domestic product and one or more of which is enclosed in a primary pack.

“Medicine” means any poison for therapeutic use.
Note: To be preceded by “human” or “veterinary” where restriction of the “medicine” to human or animal use is intended.

“Name and address” means the name and address, in Australia, of the manufacturer or distributor of a poison but does not include a post office, cable, telegraphic or code address.  Where such manufacturer or distributor is a company incorporated in accordance with the appropriate law of any State or Territory of the Commonwealth of Australia or a firm registered under the Business Names Act of any State or Territory, the inclusion in the label of the registered name of the corporation or firm or its branch or its division and the city or town in which a registered office is situated shall be deemed to comply with the requirements.

“Non-access packaging” is packaging that complies with the requirements of Australian Standard AS4710-2001 entitled Packages for chemicals not intended for access or contact with their contents by humans, in relation to products that are not intended for human therapeutic use.

See also "Child-resistant closure" and "Child-resistant packaging”.

“Non-volatile content” in relation to a paint or tinter means that portion of a paint or tinter determined to be the non-volatile content by Method 301.1 of Australian Standard AS 1580-301.1-2005 entitled Paints and related materials – Methods of test – Non-volatile content by mass.

“Oromucosal use” means administration to the oral mucosa, specifically the oral cavity and/or the pharynx.

“Paint”, without limiting the ordinary meaning, includes any substance used or intended to be used for application as a colouring or protective coating to any surface but does not include graphic material or paints for therapeutic use.

“Pesticide” means any substance or mixture of substances used or intended to be used:

a)   for preventing, destroying, repelling, attracting, inhibiting or controlling any insects, rodents, birds, nematodes, bacteria, fungi, weeds or other forms of plant or animal life or viruses, which are pests; or

b)   as a plant regulator, promoter, defoliant or desiccant for food storage, household, industrial, commercial, agricultural and non-agricultural application, but does not include veterinary drugs, stock medicines, stock feeds, stock feed additives, drugs for human use, food additives or fertilisers.

“Poison” means any substance or preparation included in a Schedule to this Standard.

“Primary pack” means the pack in which a poison and its immediate container or immediate wrapper or measure pack are presented for sale or supply.

“Product sample” means a packed poison supplied directly to the consumer free of charge or a nominal charge as a mechanism to promote the sale of the product and may be small packs produced specifically for the purposes of promotion or normal commercial packs which in other circumstances a consumer would need to purchase.

“Public Place” means any place where members of the public are lawfully entitled, invited or permitted to be present in their capacity as members of the public. For example a street, road, footway, court, alley or through-fare that the public are allowed to use, in any residential premises, door to door, place to place or house to house.

“Required Advisory Statements for Medicine Labels” means the document made under subsection 3(5A) of the Therapeutic Goods Act 1989 by the Therapeutic Goods Administration.

“Restricted flow insert” means a restriction fitted, or moulded, in the neck of a container which:

a)   cannot readily be removed from the container by manual force; and

b)   limits the delivery of the contents to drops each of which is not more than 200 microlitres.

“Second Group Paint” means a paint containing the specified proportion of any substance in the Second Group to Part 2 Section 7 of this Standard.

“Selected container” means:

a)   an injection vial having a nominal capacity of ten millilitres or less;

b)   a single use syringe; or

c)   any other container for substances for therapeutic use having a nominal capacity of ten millilitres or less.

“Solid” is considered to include “powder” for the purposes of scheduling.

“Therapeutic good” has the meaning defined in the Commonwealth Therapeutic Goods Act 1989.

“Therapeutic use” means use in or in connection with:

a)   preventing, diagnosing, curing or alleviating a disease, ailment, defect or injury in human beings or animals;

b)   influencing, inhibiting or modifying a physiological process in human beings or animals;

c)   testing the susceptibility of human beings or animals to a disease or ailment;

d)   influencing, controlling or preventing conception in human beings or animals;

e)   testing for pregnancy in human beings or animals; or

f)    the replacement or modification of parts of the anatomy in human beings or animals.

“Tinter” means any pigment or admixture of pigment with other substances, in powder, semi-solid or liquid form, sold or supplied for the purpose of adding to paint in order to change the colour of the paint.

“Topical use” means application of a poison for the purpose of producing a localised effect on the surface of the organ or within the tissue to which it is applied.

“Toy” means an object or number of objects manufactured, designed, labelled or marketed as a plaything for a child or children up to the age of 14 years.

“Transdermal use” means application to the skin primarily for systemic effect.

“Veterinary chemical” means a substance that is represented as being suitable for, or is manufactured, supplied or used for, administration or application to an animal by any means, or consumption by an animal, as a way of directly or indirectly:

a)   preventing, diagnosing, curing or alleviating a disease or condition in the animal or an infestation of the animal by a pest;

b)   curing or alleviating an injury suffered by the animal;

c)   modifying the physiology of the animal:

i)so as to alter its natural development, productivity, quality or reproductive capacity; or

ii)so as to make it more manageable;

d)   modifying the effect of another veterinary chemical

e)   any vitamin, mineral substance, or additive, if, and only if, the vitamin, substance or additive is used for a purpose mentioned in paragraph (a), (b), (c) or (d); or

f)    any active ingredient included in a product declared by regulation under the Agricultural and Veterinary Chemicals Code Act 1994 to be an veterinary chemical product;

but does not include:

g)   an agricultural chemical.

“Veterinary chemical product” has the meaning defined in the Agricultural and Veterinary Chemicals Code Act 1994.

“Writing” includes the visible representation or reproduction of words or figures in any form, and “to write” and “written” have corresponding meanings.

(2) Unless the contrary intention appears a reference to a substance in a Schedule or an Appendix to this Standard includes:

a)   that substance prepared from natural sources or artificially; and

b)   where the substance is a plant (other than a plant included in Schedule 8 or 9), that plant or any part of that plant when packed or prepared for therapeutic use; and

c)   every salt, active principle or derivative of the substance, including esters and ethers, and every salt of such an active principle or derivative; and

d)   every alkaloid of the substance and every salt of such an alkaloid; and

e)   every stereoisomer of the substance and every salt of such a stereoisomer; and

f)    every recombinant form of the substance; and       

g)   a preparation or admixture containing any proportion of the substance,

but does not include:

h)   a preparation or product included in Appendix A, or a substance and the reason for its entry in Appendix B; or

i)    a substance included in Appendix G at a concentration not exceeding the concentration specified in column 2 of that Appendix in respect of that substance; or

j)    any other substance included in Schedules 1 to 6, at a concentration not exceeding 10 mg per litre or 10 mg per kilogram, unless that substance is also included in Schedule 7 or 8; or

k)   any substance present as an impurity in a pesticide, at a concentration at or below the maximum content for that substance, specified for the pesticide in the Standards for Active Constituents, as published by the Australian Pesticides and Veterinary Medicines Authority.

(3) Unless the contrary intention appears where a concentration, strength or quantity is specified in a Schedule or an Appendix to this Standard in respect of a substance:

a)   if the substance is present as a salt, active principle or derivative (including an ester or ether), the concentration, strength or quantity is calculated as the equivalent amount of the substance that is listed in the Schedule or Appendix; and

b)   the expression “one per cent” means:

i)in the case of a liquid preparation, 1 gram of the substance per 100 millilitres of the preparation; or

ii)in the case of a solid, semi-solid or pressurised spray aerosol preparation, 1 gram of the substance per 100 grams of the preparation; and

iii)any expression of greater or lesser percentages shall have a corresponding meaning; and

c)   in the case of codeine, such concentration, strength or quantity is calculated as anhydrous codeine.

(4) A reference to a boiling or distillation temperature in the Schedules means that temperature at an atmospheric pressure of 101.325 kPa (760 millimetres of mercury).

PART 2

CONTROL ON MEDICINES AND POISONS

SECTION ONE LABELS

1.1       General requirements

(1) A person must not sell or supply a poison unless it is labelled in accordance with Part 2 Section 1 of this Standard.

(2) Any word, expression or statement required by this Standard to be written on a label or container must be written:

a)   on the outside face of the label or container; and

b)   in the English language; and

c)   in durable characters; and

d)   in a colour or colours to provide a distinct contrast to the background colour; and

e)   in letters at least 1.5 millimetres in height.

(3) Section 1.1(2)(e) does not apply to a word, expression or statement on a container which has a capacity of 20 millilitres or less, or on the label of such a container if:

a)   an appropriate authority approves the use of smaller letters; and

b)   the letters are at least 1 millimetre in height.

(4) The label must be printed on, or securely attached to:

a)   the outside of the immediate container; and

b)   if the immediate container is enclosed in a primary pack, the outside of that primary pack.

1.2       Immediate wrapper

(1) A poison enclosed in an immediate wrapper must be contained in a primary pack labelled in accordance with Section 1.3 of this Standard; and

(2) the immediate wrapper must be conspicuously labelled with:

a)   the name of the manufacturer or distributor or the brand name or trade name used exclusively by the manufacturer or distributor for that poison; and

b)   the approved name of the poison; and

c)   a statement of the quantity or strength of the poison in accordance with Section 1.4 of this Standard.

1.3       Primary packs and immediate containers

(1) The primary pack and immediate container of a poison must be labelled as follows:

a)   with the signal word or words relating to the Schedule in which the poison is included and the purpose for which it is to be used, as shown in the following table:

Schedule	Purpose	Signal words required
2	for any purpose	PHARMACY MEDICINE
3	for any purpose	PHARMACIST ONLY MEDICINE
4	for human use	PRESCRIPTION ONLY MEDICINE
4	for animal use	PRESCRIPTION ANIMAL REMEDY
5	for any purpose	CAUTION
6	for any purpose	POISON
7	for any purpose	DANGEROUS POISON
8	for any purpose	CONTROLLED DRUG

written:

i)on the first line or lines of the main label; and

ii)in bold-face sans serif capital letters of uniform thickness; and

iii)in letters at least half the height of the largest letter or numeral on the label but need not be larger than:

A)    6 millimetres on labels for packages having a nominal capacity of 2 litres or less; or

B)    15 millimetres on labels for packages having a nominal capacity of more than 2 litres; and 

iv)if the poison:

A)   is a Schedule 5 poison, with nothing, other than a Class label as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail or a statement of the principal hazard of the poison, written on that line; or

B)    is not a Schedule 5 poison, with nothing, other than a Class label as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail, written on that line;

b)   if the poison is a Schedule 8 poison, with the cautionary statement –

POSSESSION WITHOUT AUTHORITY ILLEGAL

written:

i)on a separate line or lines immediately below the signal words required by Section1.3(1)(a); and

ii)in bold-face sans serif capital letters of uniform thickness; and

iii)in letters at least four-tenths the height of the letters used for the signal words; and

iv)with no other statement written on the same line;

c)   with the cautionary statement –

KEEP OUT OF REACH OF CHILDREN

written:

i)on a separate line or lines:

A)   immediately below the signal word or words required by Section 1.3(1)(a); or

B)    where the cautionary statement “POSSESSION WITHOUT AUTHORITY ILLEGAL” is required by Section 1.3(1)(b), on the line immediately below that statement; and

ii)in bold-face sans serif capital letters of uniform thickness; and

iii)in letters at least four-tenths the height of the letters used for the signal word or words; and

iv)with nothing, other than a Class label as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail, written on the same line;

d)   if the poison is a dry chlorinating compound containing more than 10 per cent of available chlorine, except for preparations certified by a relevant State or Territory authority as not being a Dangerous Good of Class 5, Division 5.1: Oxidising substances, as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail, with the cautionary statement –

FIRE AND EXPLOSION HAZARD

written:

i)on a separate line or lines immediately below the cautionary statement “KEEP OUT OF REACH OF CHILDREN” as required by Section 1.3(1)(c); and

ii)in bold-face sans serif capital letters of uniform thickness; and

iii)in letters at least four-tenths the height of the letters used for the signal word or words; and

iv)with nothing, other than a Class label as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail, written on the same line;

e)   if the poison is an alkaline salt in a dishwashing machine product, with the cautionary statement –

BURNS SKIN AND THROAT

written:

i)on a separate line or lines immediately below the cautionary statement “KEEP OUT OF REACH OF CHILDREN” as required by Section 1.3(1)(c); and

ii)in bold-face sans serif capital letters of uniform thickness; and

iii)in letters at least four-tenths the height of the letters used for the signal word; and

iv)with nothing, other than a Class label as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail, written on the same line of the main label;

f)    if the poison is an aqueous solution of paraquat, with the cautionary statements –

CAN KILL IF SWALLOWED
DO NOT PUT IN DRINK BOTTLES
KEEP LOCKED UP

written:

i)on separate lines immediately below the cautionary statement “KEEP OUT OF REACH OF CHILDREN” as required by Section1.3(1)(c); and

ii)in bold-face sans serif capital letters of uniform thickness; and

iii)in letters at least four-tenths the height of the letters used for the signal words; and

iv)with nothing, other than a Class label as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail, written on the same lines of the main label;

g)   for any poison other than a poison for human therapeutic use labelled in accordance with the Required Advisory Statements for Medicine Labels, if safety directions are required on the label by Section 1.3(1)(n), with the cautionary statement –

READ SAFETY DIRECTIONS BEFORE OPENING  
OR USING

or with the cautionary statement –

READ SAFETY DIRECTIONS

written:

i)on a separate line or lines;

A)   immediately below the cautionary statement “KEEP OUT OF REACH OF CHILDREN” as required by Section (1)(c); or

B)    if one or more other cautionary statements is required to be on the line immediately below “KEEP OUT OF REACH OF CHILDREN”, immediately below that statement or those statements; and

ii)in bold-face sans serif capital letters of uniform thickness; and

iii)in letters at least four-tenths the height of the letters used for the signal word or words; and

iv)with nothing, other than a Class label as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail, written on the same line;

h)   if the poison meets the criteria for a ‘flammable liquid’ in the Australian Code for the Transport of Dangerous Goods by Road and Rail, with the cautionary statement –

FLAMMABLE

written on the main label in bold-face sans serif capital letters of uniform thickness,             unless already present in accordance with the requirements of the Australian Code for         the Transport of Dangerous Goods by Road and Rail;

i)    if the poison is for the treatment of animals, with the cautionary statement –

FOR ANIMAL TREATMENT ONLY

written on the main label in bold-face sans serif capital letters of uniform                  thickness;

j)    if the poison is a Schedule 5 poison intended for any purpose other than internal or pesticidal use, with the cautionary statement –

DO NOT SWALLOW

written in sans serif capital letters on the main label or as part of the              directions for use;

k)   with the approved name of the poison and a statement of the quantity, proportion or strength of the poison in accordance with Section 1.4:

i)if the poison is for human therapeutic use, written in accordance with orders made under subsection 10(3) of the Commonwealth Therapeutic Goods Act, 1989; or

ii)if the poison is not for human therapeutic use, written in bold-face sans serif capital letters on the main label, unless:

A)   list of approved names is required; and

B)    it is impractical to include the list on the main label; and

C)    an appropriate authority has authorised its inclusion on another part of the label; or

iii)if the poison is a Schedule 5 poison referred to in column 1 of the following table the appropriate name opposite thereto in column 2 may be used as the approved name:

TABLE

Column 1	Column 2
Alkaline salts	Alkaline salts
Amines for use as curing agents for epoxy resins (unless separately specified in the Schedules)	Aliphatic amines or aromatic amines
Epoxy resins, liquid	Liquid epoxy resins
Hydrocarbons, liquid	Liquid hydrocarbons
Quaternary ammonium compounds	Quaternary ammonium compound(s)

iv)if a poison contains a mixture of designated solvents in excess of 25 per cent of the total volume of the poison but the proportion of one or more individual designated solvents in the mixture is equal to or less than 25 per cent, the approved names of those solvents may be expressed as follows:

A)   where the designated solvent is a liquid hydrocarbon as “liquid hydrocarbons”; or

B)    where the designated solvent is a ketone as “ketones”; or

C)    in any other case as “solvents” or “other solvents”;

l)    if the poison is an organophosphorus compound or carbamate for pesticidal use or for the treatment of animals, with the following expression written immediately below the approved name or the list of declared contents –

AN ANTICHOLINESTERASE COMPOUND

i)the requirements of Section 1.3(1)(l) do not apply to:

A)   dazomet, mancozeb, metiram, propineb, thiram, tri-allate, zineb or ziram; or

B)    an organophosphorus compound or carbamate contained in impregnated plastic resin strips, medallions or granules; or

C)    an organophosphorus compound or carbamate contained in a        pressurised spray pack for household use;

m)    for any poison other than a poison for human therapeutic use labelled in accordance with Therapeutic Goods Order 69 General requirements for labels for medicines or in an agricultural or veterinary chemical product labelled in compliance with the Agricultural and Veterinary Chemicals Code Act 1994, if the poison is prepared, packed or sold for a specific purpose, with clear and adequate directions for use unless:

i)the poison is included in Schedule 4 or Schedule 8; or

ii)it is impractical to include such directions on the label and:

A)            the primary pack and the immediate container are labelled with the statement “DIRECTIONS FOR USE: See package insert”; and

B)an appropriate authority has authorised the directions for use to be written on a package insert instead of the label; and

C)the insert is enclosed in the primary pack;

n)   for any poison other than a poison for human therapeutic use labelled in accordance with the Required Advisory Statements for Medicine Labels, if use of the poison may be harmful to the user, with appropriate safety directions (see Appendix F), grouped together as a distinct section of the label and prefaced by the words –

SAFETY DIRECTIONS

written in bold-face capital letters;

o)   for any poison other than a poison for human therapeutic use labelled in accordance with the Required Advisory Statements for Medicine Labels, if any warning statement or statements are required for the poison (see Appendix F), with that warning statement or those statements grouped together:

i)if safety directions are included on the label, immediately after the words “SAFETY DIRECTIONS”; or

ii)if there are no safety directions, immediately preceding the directions for use;

p)   if the poison is not for human internal use and is not a Schedule 3, Schedule 4 or Schedule 8 poison, with appropriate first aid instructions (see Appendix E):

i)grouped together and prefaced by the words –

FIRST AID

written in bold-face capital letters; or

ii)if a primary pack contains two or more immediate containers of poisons each requiring different first aid instructions:

A)   written on each immediate container as specified in Section 1.3(1)(p)(i); and

B)    replaced on the primary pack with the statement –

FIRST AID: See inner packs;

q)   with the name and address of the manufacturer or distributor.

(2) For the purposes of Section 1.3(1)(a)(iii) the term “largest letter or numeral” does not include:

a)   a single letter or numeral which is larger than other lettering on the label; or

b)   an affix forming part of the trade name; or

c)   in the case of a poison for therapeutic use, numerals used to distinguish the strength of a preparation from the strengths of other preparations of the same poison.

1.4       Statements of quantity, proportion or strength

(1) The statement of the quantity, proportion or strength of a poison must be expressed in the most appropriate of the following forms:

a) if the poison is for human therapeutic use, in the manner prescribed by orders made under subsection 10(3) of the Commonwealth Therapeutic Goods Act 1989;

b)   if the poison is for a purpose or purposes other than human therapeutic use and:

i)if the poison is in a pressurised spray aerosol preparation, as the mass of the poison per stated mass of the preparation;

ii)if the poison is a liquid in a liquid preparation, as the mass or volume of the poison per stated volume of the preparation;

iii)if the poison is a liquid in a solid or semi-solid preparation, as the mass or volume of the poison per stated mass of the preparation;

iv)if the poison is a solid or semi-solid in a liquid preparation, as the mass of the poison per stated volume of the preparation;

v)if the poison is a solid or semi-solid in a solid or semi-solid preparation, as the mass of the poison per stated mass of the preparation;

vi)if the poison is a gas in a liquid preparation, as the mass of the poison per stated volume of the preparation;

vii)if the poison is a gas in a solid or semi-solid preparation, as the mass of the poison per stated mass of the preparation;

viii)if the poison is a gas in a gaseous preparation, as the mass of the poison per stated mass of the preparation;

c)   if the poison is a solution of a mineral acid, the proportion of the acid (un-neutralised by any bases present in the preparation) in a preparation may be expressed as the un-neutralised mass of the acid per stated mass of the preparation;

d)   if the poison is an inorganic pigment, the proportion may be expressed as a percentage of the metal present using one of the following expressions as appropriate:

contains not more than 10 per cent of (insert name of the metal);       or

contains not more than 30 per cent of (insert name of the metal); or

contains more than 30 per cent of (insert name of the metal);

e)   if the poison is included in a paint, other than a paint for therapeutic or cosmetic use, the proportion may be expressed as a range provided that the limits of the range do not differ by more than 5 per cent of the product;

f)    if the poison is a lead-based pigment included in automotive paint, the proportion may be expressed as the maximum content of the lead that may be present in the non-volatile content of the paint;

g)   if a preparation contains more than one derivative of a poison, the quantity or proportion of the poison may be expressed as the equivalent quantity or proportion of one of the derivatives present which it would contain if all of the derivatives were that derivative.

h)   for the purposes of Section 1.4(1)(g) “derivative” includes alkaloid.

1.5       Exemptions

1.5.1    Selected containers and measure packs

(1) The requirements of Section 1.3 do not apply to an immediate container that is a measure pack or a selected container (other than an ampoule, a pre-filled syringe or an injection vial to which Section 1.5.2 (1) and (2) apply) when:

a) the immediate container is for a therapeutic good and is labelled in the manner prescribed by orders made under subsection 10(3) of the Commonwealth Therapeutic Goods Act 1989; or

b)   the immediate container is:

i)packed in a primary pack labelled in accordance with Section 1.3; and

ii)labelled with:

A)   the signal word or words relating to the Schedule in which the poison is included and the purpose for which it is to be used, as shown in the table to Section 1.3(1)(a); and

B)    the approved name of the poison and the quantity, proportion or strength of the poison in accordance with Section 1.4; and

C)    the name of the manufacturer or distributor or the brand name or trade name used exclusively by the manufacturer or distributor for the poison; and

D)   if the poison is for the treatment of animals, with the cautionary statement –

FOR ANIMAL TREATMENT ONLY

written in sans serif capital letters.

1.5.2    Ampoules, pre-filled syringes and injection vials

(1) The requirements of Section 1.3 do not apply to a selected container, or an ampoule (other than an ampoule to which Section 1.5.2(2) applies) when:

a) the selected container or ampoule is for a therapeutic good and is labelled in the manner prescribed by orders made under subsection 10(3) of the Commonwealth Therapeutic Goods Act 1989; or

b)   the selected container or ampoule is:

i)packed in a primary pack labelled in accordance with Section 1.3; and

ii)labelled with:

A)   the approved name of the poison and the quantity, proportion or strength of the poison in accordance with Section 1.4; and

B)    with the name of the manufacturer or distributor or the brand name or trade name used exclusively by the manufacturer or distributor for the poison; and

C)    if the poison is for the treatment of animals, with the cautionary statement –

FOR ANIMAL TREATMENT ONLY

written in sans serif capital letters.

(2) The requirements of Section 1.3 do not apply to a selected container that is a plastic ampoule that is continuous with a strip of the same material and opens as it is detached from the strip when:

a) the selected container is a plastic ampoule that is continuous with a strip of the same material and opens as it is detached from the strip, is for a therapeutic good and is labelled in the manner prescribed by orders made under subsection 10(3) of the Commonwealth Therapeutic Goods Act 1989; or

b)   the selected container is a plastic ampoule that is continuous with a strip of the same material and opens as it is detached from the strip, is:          

i)packed in a primary pack labelled in accordance with Section 1.3; and

ii)the strip is labelled in accordance with Section 1.5.2; and

iii)the ampoule is labelled with:

A)   the approved name of the poison or the trade name of the product; and

B)    the quantity, proportion or strength of the poison in accordance with Section 1.4.

1.5.3    Transport containers and wrappings

(1) The labelling requirements of this Standard do not apply to a transparent cover, or to any wrapper, hamper, packing case, crate or other cover used solely for the purposes of transport or delivery.

1.5.4    Dispensary, industrial, laboratory and manufacturing poisons

(1) The labelling requirements of this Standard do not apply to a poison that:

a)   is packed and sold solely for dispensary, industrial, laboratory or manufacturing purposes; and

b)   is labelled in accordance with Safe Work Australia's National Code of Practice for the Labelling of Workplace Substances [NOHSC: 2012(1994)].

1.5.5    Exemptions from label requirements in certain circumstances

(1) the labelling requirements of Sections 1.3 to 1.5.3 do not apply to a poison where an appropriate authority has granted a labelling exemption in whole or in part for these sections for a specified product; and

(2) the labelling exemption from an appropriate authority referred to in Section 1.5.5(1) is limited to no more than 12 months from the effective date of the decision for retail supply of the product; and

(3) for the avoidance of doubt this paragraph does not apply to exemptions issued under Section 1.3(1)(m)(ii)(B) of this Standard.

1.5.6    Dispensed medicines

(1) Unless otherwise specified by regulation:

a)   The labelling requirements of this Standard do not apply to a medicine that:

i)is supplied by an authorised prescriber or other person authorised to supply and is labelled in accordance with the requirements of Appendix L Part 1 of this Standard; or

ii)is supplied on and in accordance with a prescription written by an authorised prescriber and is labelled in accordance with the requirements of Appendix L Part 1 of this Standard; or

iii)is prepared and supplied by a pharmacist for an individual patient and is labelled in accordance with the requirements of Appendix L Part 1 of this Standard.

b)   A person must not supply a dispensed medicine for human use containing:

i)a poison listed in column 1 of the table at Appendix L Part 2 of this Standard unless it is clearly labelled with the warning statement(s) specified in column 2 of that table; or

ii)a poison listed in Appendix K unless it is clearly labelled with a sedation warning (being statement 39, 40 or 90 as specified in Appendix F Part 1 of this Standard).

1.5.7    Gas cylinders

(1) The requirements of Sections 1.3(1)(a)(iv), 1.3(1)(c)(iv), and 1.3(1)(g)(iv) do not apply to a cylinder containing a poison that is a compressed gas.

1.5.8    Paints

(1) The requirements of Section 1.3 do not apply to:

a)   paint (other than a paint for therapeutic or cosmetic use) which:

i)contains only Schedule 5 poisons; or

ii)is a First Group or Second Group paint that is labelled with:

A)   the word “WARNING”, written in bold-face sans serif capital letters, the height of which is not less than 5 mm, on the first line of the main label with no other words written on that line; and

B)    the expression “KEEP OUT OF REACH OF CHILDREN”, written in bold-face sans serif capital letters, the height of which is not less than 2.5 mm, on a separate line immediately below the word “WARNING”; and

C)    the appropriate warnings specified for the paint in Appendix F, written immediately below the expression “KEEP OUT OF REACH OF CHILDREN”; and

D)   the name and proportion of the First Group or Second Group poisons it contains, provided that where the substance is a metal or metal salt the proportion is expressed as the metallic element present “calculated on the non-volatile content” or “in the dried film” of the paint; or

b)   a tinter which contains:

i)only Schedule 5 poisons; or

ii)a poison included in the First Group or Second Group in Part 2 Section 7, provided that it is labelled with the name and proportion of that poison, and where the poison is a metal or metal salt, the proportion is expressed as the metallic element present as “calculated on the non-volatile content” or “in the dried film”.

1.5.9    Camphor and naphthalene

(1) The labelling requirements of Section1.1(2)(d) and Section 1.3 do not apply to a device that contains camphor or naphthalene in block, ball, disc, pellet or flake form if the device:

a)   complies with Section 2.7; and

b)   is sold or supplied in a primary pack labelled in accordance with Section 1.1 and Section 1.3.

1.6       Prohibitions

(1) A label used in connection with any poison must not include:

a)   any reference to this Standard, or any comment on, reference to, or explanation of any expression required by this Standard that directly or by implication contradicts, qualifies or modifies such expression; or

b)   any expression or device suggesting or implying that the poison is safe, harmless, non-toxic, non-poisonous, or is recommended or approved by the Government or any government authority unless required by legislation; or

c)   any expression or device which is false or misleading in any particular concerning the safety of the poison or any of its ingredients; or

d)   any trade name or description that:

i)represents any single constituent of a compound preparation; or

ii)misrepresents the composition or any property or quality of the poison; or

iii)gives any false or misleading indication of origin or place of manufacture of the poison.

(2) A label must not be attached to the immediate container or primary pack used in connection with any poison in such a manner as to obscure:

a)   any expression required by this Standard to be written or embossed on the container or pack; or

b)   any of the ribs or embossed or printed words required by paragraph 21, 22 or 23 as appropriate.

SECTION TWO CONTAINERS

2.1       Containers for poisons other than Schedule 5 poisons

(1)  A person must not sell or supply a poison unless the immediate container complies with the requirements of Sections 2.1 and 2.3 to 2.7 of this Standard.

(2) If a poison, other than a Schedule 5 poison, is sold or supplied in a container with a nominal capacity of 2 litres or less, the container must comply with Australian Standard AS 2216-1997, entitled Packaging for poisonous substances.

(3) Notwithstanding Section 2.1(2), a poison which is in Schedule 6 and is an essential oil may be packed in an amber glass container which does not comply with the tactile identification requirements of Australian Standard AS 2216-1997, entitled Packaging for poisonous substances, if:

a)   the other safety factors are not diminished; and

b)   the container has a restricted flow insert and a child-resistant closure.

(4) If a poison, other than a Schedule 5 poison, is sold or supplied in a container with a nominal capacity of more than 2 litres, the container must:

a)   comply with subsection 1.4 (General Requirements) of Australian Standard AS 2216-1997 entitled Packaging for poisonous substances; and

b)   have the word “POISON”:

i)in sans serif capital letters the height of which is at least one thirty second part of the length, height or width of the container, whichever is the greatest:

A)   embossed; or

B)    indelibly written in a colour in distinct contrast to the background colour;

ii)on the side or shoulder of the container.

2.2       Containers for Schedule 5 poisons

(1) The container in which any Schedule 5 poison is sold or supplied must:

a)   comply with the container requirements of Sections 2.1(2) or 2.1(4); or

b)   be readily distinguishable from a container in which food, wine or other beverage is sold; and

i)comply with subsection 1.4 (General Requirements) of Australian Standard AS 2216-1997 entitled Packaging for poisonous substances, excluding paragraph 1.4.3;

ii)be securely closed and, except when containing a preparation for use on one occasion only, be capable of being re-closed to prevent spillage of its contents; and

iii)have the expression “POISON”, “NOT TO BE TAKEN” or “NOT TO BE USED AS A FOOD CONTAINER” embossed or indelibly written thereon, or printed on a permanent adhesive label designed to adhere to a substrate without lifting and which cannot be removed without damaging either the label or the substrate.

(2) Notwithstanding Section 2.2(1), the following Schedule 5 poisons namely:

a)   methylated spirit(s);

b)   liquid hydrocarbons when packed as kerosene, lamp oil, mineral turpentine, thinners, reducers, white petroleum spirit or dry cleaning fluid;

c)   petrol;

d)   toluene; or

e)   xylene,

must not be sold or supplied in a bottle or jar having a nominal capacity of 2 litres or less, unless the immediate container complies with the container requirements specified in Section 2.1(2).

2.3       Approved containers

(1) Notwithstanding section 2.1(2), 2.1(4) and 2.2 a poison may be packed in a container that does not comply with the tactile identification requirements of Australian Standard AS2216-1997 entitled Packaging for poisonous substances or the requirements of Section 2.1(4)(b) or Section 2.2(1)(b)(iii) if:

a)   the other safety factors are not diminished;

b)   the container is for a specific purpose; and

c)   an appropriate authority has approved the use of the container for that purpose.

2.4       Child-resistant closures

(1) If a poison, other than a poison included in a therapeutic good packaged in a manner compliant with orders made under subsection 10(3) of the Commonwealth Therapeutic Goods Act 1989, listed in column 1 of the following table is sold or supplied in a container having a nominal capacity specified for that poison in column 2, it must be closed with a child-resistant closure.

Column 1 Name of the poison	Column 2 Nominal capacity
Alkaline salts included in Schedule 5, when packed and labelled as dishwashing machine tablets.	All sizes
Alkaline salts included in Schedule 5, when packed and labelled as dishwashing machine liquids, solids or gels.	5 litres /kilograms or less
Alkaline salts included in Schedule 5, when packed and labelled as a food additive.	2.5 litres or less
Anise oil when included in Schedule 5.	200 millilitres or less
Basil oil when included in Schedule 5.	200 millilitres or less
Bay oil when included in Schedule 6.	200 millilitres or less
Cajuput oil when included in Schedule 6.	200 millilitres or less
Cassia oil when included in Schedule 5.	200 millilitres or less
Cineole when included in Schedule 6.	2 litres or less
Cinnamon bark oil when included in Schedule 5.	200 millilitres or less
Cinnamon leaf oil when included in Schedule 6.	200 millilitres or less
Clove oil when included in Schedule 6.	200 millilitres or less
Essential oils when included in Schedule 6 because of their natural camphor component.	200 millilitres or less
Ethylene glycol when included in Schedule 6.	5 litres or less
Ethylene glycol when included in Schedule 5 in preparations containing more than 50 per cent of ethylene glycol.	5 litres or less
Eucalyptus oil when included in Schedule 6.	2 litres or less
Eugenol when included in Schedule 6.	200 millilitres or less
Hydrocarbons, liquid, when packed as kerosene, lamp oil, mineral turpentine, thinners, reducers, white petroleum spirit or dry cleaning fluid.	5 litres or less
Hydrochloric acid when included in Schedule 6.	5 litres or less
Leptospermum scoparium oil (manuka oil) when included in Schedule 6	200 millilitres or less
Marjoram oil when included in Schedule 5.	200 millilitres or less
Melaleuca oil (tea-tree oil) when included in Schedule 6.	200 millilitres or less
Methylated spirit excluding preparations or admixtures.	5 litres or less
Methyl salicylate and preparations containing more than 50 per cent of methyl salicylate.	200 millilitres or less
Nutmeg oil when included in Schedule 5.	200 millilitres or less
Oil of turpentine.	5 litres or less
Pennyroyal oil when included in Schedule 6.	200 millilitres or less
Potassium hydroxide as such.	2.5 litres or less
Potassium hydroxide in oven, hot plate or drain cleaners when included in Schedule 6 except when in pressurised spray packs.	5 litres or less
d-Pulegone when included in Schedule 6.	200 millilitres or less
Sage oil (Dalmatian) when included in Schedule 6.	200 millilitres or less
Sodium hydroxide as such.	2.5 litres or less
Sodium hydroxide in oven, hot plate or drain cleaners when included in Schedule 6 except when in pressurised spray packs.	5 litres or less
Thujone when included in Schedule 6.	200 millilitres or less
Thyme oil when included in Schedule 5.	200 millilitres or less

(2) The manufacturer or packer of a poison must ensure that the child-resistant closure is appropriate for the container and the poison and that it retains its child-resistant properties for the expected life of the poison.

2.5       Schedule 8 poisons

(1)  A person who supplies any Schedule 8 poison must ensure that the Schedule 8 poison is packaged in such a way that its primary pack is so sealed that, when the seal is broken, it is readily distinguishable from other sealed primary packs.

(2) This paragraph does not apply to the supply of a Schedule 8 poison by an:

a)   authorised prescriber or other authorised supplier;

b)   pharmacist on the prescription of an authorised prescriber;

c)   pharmacist employed at a hospital, on the written requisition of a medical practitioner, a dentist or the nurse or midwife in charge of the ward in which the Schedule 8 poison is to be used or stored; or

d)   nurse or midwife on the direction in writing of an authorised prescriber.

2.6       Exemptions

(1) Section 2.1(2), Section 2.1(4) and Section 2.2 do not apply to the immediate container of a poison prepared, packed and sold:

a)   for human internal or animal internal use; or

b)   as a solid or semi-solid preparation for human external or animal external use; or

c)   as a paint, other than a paint for therapeutic or cosmetic use; or

d)   in containers having a nominal capacity of 15 millilitres or less; or

e)   for use in automatic photographic or photocopy processing machines if the container is specifically designed to fit into the machines; or

f)    solely for dispensary, industrial, laboratory or manufacturing purposes.

(2) Section 2.4 does not apply to a poison prepared, packed and sold solely for dispensary, industrial, laboratory or manufacturing purposes.

(3) The tactile identification or embossing required by Section 2.1(2), Section 2.1(4) and Section (2.2) of this Standard or Australian Standard AS 2216-1997 entitled Packaging for poisonous substances do not apply to a container that is an aerosol container, a collapsible tube, or a measure pack which is a flexible sachet.

2.7       Camphor and naphthalene

(1) The container requirements of Section 2.1(2) do not apply to a device that contains only camphor or naphthalene in block, ball, disc, pellet or flake form for domestic use, if the device:

a)   in normal use, prevents removal or ingestion of its contents; and

b)   is incapable of reacting with the poison; and

c)   is sufficiently strong to withstand the ordinary risks of handling, storage or transport; and

d)   has the word “POISON” and the approved name of the poison embossed or indelibly printed on it.

(2) A person must not sell or supply camphor or naphthalene in ball, block, disc, pellet or flake form for domestic use unless the balls, blocks, discs, pellets or flakes are enclosed in a device which prevents removal or ingestion of its contents.

2.8       Prohibitions

(1) A person must not sell or supply a poison in a container which has the name of another poison embossed or indelibly marked thereon.

(2) A person must not sell any poison which is for internal use or any food, drink or condiment in a container prescribed by Sections 2.1(2), 2.1(4) and Section 2.2 of this Standard.

(3) A person must not sell any poison in a container that is not readily distinguishable from a container in which food, alcohol, other beverage or condiment is sold.

SECTION THREE      STORAGE           

3.1       General requirements

(1)  A person who sells or supplies Schedule 6 poisons by way of retail sale must keep those poisons in such a way as to prevent access by children.

(2) A person who sells or supplies Schedule 7 poisons must not keep those poisons for retail sale in any areas or in any area or in any manner that allows physical access by any person unless they are:

a)   the owner of the retail establishment; or

b)   an employee of the owner; or

c)    legally permitted to purchase the substance and are under the supervision of the owner or an employee of the owner.

(3) Controls on storage of Schedule 2, 3, 4 and 8 poisons require referral to Part 3 of this Standard and relevant legislation.

SECTION FOUR DISPOSAL

4.1       General requirements 

(1) A person must not dispose of or cause to be disposed of a Schedule 5, Schedule 6 or Schedule 7 poison in any place or manner that constitutes or is likely to constitute a risk to public health or safety.

(2) Controls on disposal of Schedule 2, 3, 4 and 8 poisons require referral to relevant legislation.

SECTION FIVE RECORD KEEPING               

5.1       General Requirements

(1) A person who sells or supplies Schedule 7 poisons must keep a record of:

a)   Name and address of seller or supplier and purchaser; and

b)   Date of order and supply; and

c)   Approved name or trade name that identifies the poison to be supplied or sold; and

d)   Quantity supplied or sold; and

e)   Proof of purchaser authorisation must be recorded in jurisdictions where an authorisation is required for purchase.

(2) Records for sale or supply of Schedule 7 poisons must be kept for a minimum period of five years.

(3) Controls on record keeping for sale or supply of Schedule 2, 3, 4 and 8 poisons require referral to relevant legislation.

SECTION SIX    SALE, SUPPLY, POSSESSION, or USE

6.1       General Requirements for Schedule 5 and Schedule 6 Product samples

(1) A person must not sell or supply or distribute free a product sample containing a Schedule 5 or Schedule 6 poison in any manner unless the recipient has the opportunity to refuse at the time of sale or supply.

(2) A person must not sell or supply or distribute free a product sample containing a Schedule 5 or Schedule 6 poison in an unsolicited manner for example via the post / mailbox or attached to any other product.

(3) A person must not sell or supply a Schedule 5 or Schedule 6 poison product sample in a manner that does not promote disposal in accordance with section four.

6.2    Schedule 7 Poisons

(1) A person must not possess or use a Schedule 7 poison for domestic or domestic garden purposes.

(2) A person must not sell or supply:

a)   a Schedule 7 poison for domestic or domestic garden purposes; or

b)   a Schedule 7 poison being a liquid preparation containing paraquat unless it is coloured blue or green and contains sufficient stenching agent to produce an offensive smell; or

c)   a Schedule 7 poison for which an authorisation to purchase, possess or use is required by the appropriate authority unless the purchaser produces his or her authorisation. 

(3) A person must not sell, supply or distribute free product samples containing Schedule 7 poisons.

POTASSIUM PERSULFATE

Schedule 6
Appendix E, Part 2
Appendix F, Part 3

POTASSIUM SORBATE

Appendix B, Part 3

POTASSIUM SULFIDE

Schedule 5
Appendix E, Part 2
Appendix F, Part 3

PRACTOLOL

Schedule 4

PRADOFLOXACIN

Schedule 4

PRALATREXATE

Schedule 4

PRALIDOXIME

Schedule 4

PRALLETHRIN

Schedule 6
Schedule 5

PRALMORELIN ((GROWTH HORMONE RELEASING PEPTIDE-2) (GHRP-2)

Schedule 4
Appendix D, Item 5

PRAMIPEXOLE

Schedule 4

PRAMOCAINE

Schedule 4

PRAMPINE

Schedule 4

PRASTERONE
cross reference: DEHYDROEPIANDROSTERONE, DEHYDROISOANDROSTERONE

Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)

PRASUGREL

Schedule 4

PRAVASTATIN

Schedule 4

PRAZEPAM

Schedule 4
Appendix D, Item 5 (Benzodiazepine derivatives)
Appendix K

PRAZIQUANTEL

Schedule 4

PRAZOSIN

Schedule 4

PREDNISOLONE

Schedule 4

PREDNISONE

Schedule 4

PREGABALIN

Schedule 4
Appendix K

PREGNENOLONE

Schedule 4

PRENALTEROL

Schedule 4

PRENYLAMINE

Schedule 4

PRILOCAINE

Schedule 4
Schedule 2

PRIMAQUINE

Schedule 4

PRIMIDONE

Schedule 4

PRINTING INKS or INK ADDITIVES

Appendix A

PROBENECID

Schedule 4

PROBUCOL

Schedule 4

PROCAINAMIDE

Schedule 4

PROCAINE

Schedule 4

PROCAINE PENICILLIN

Schedule 4

PROCARBAZINE

Schedule 4

PROCHLORAZ

Schedule 6

PROCHLORPERAZINE

Appendix K

PROCHLORPERAZINE

Schedule 4
Schedule 3

PROCYCLIDINE

Schedule 4
Schedule 2

PROCYMIDONE

Schedule 7

PROFENOFOS

Schedule 6

PROFOXYDIM

Schedule 5

PROGESTERONE

Schedule 5
Schedule 4
Appendix G

PROGESTOGENS

Schedule 4

PROGLUMIDE

Schedule 4

PROGUANIL

Schedule 4

PROHEPTAZINE

Schedule 9

PROHEXADIONE CALCIUM

Schedule 5

PROLINTANE

Schedule 4

PROMACYL

Schedule 6

PROMAZINE

Schedule 4
Appendix K

PROMETHAZINE

Schedule 4
Schedule 3
Schedule 2
Appendix K

PROMETRYN

Schedule 5

PROMOXOLANE

Schedule 4

PROPACHLOR

Schedule 6

PROPAFENONE

Schedule 4

PROPAMIDINE

Schedule 4
Schedule 2

PROPAMOCARB

Schedule 5

PROPANIDID

Schedule 4

PROPANIL

Schedule 5

PROPANTHELINE

Schedule 4

PROPAQUIZAFOP

Schedule 5

PROPARGITE

Schedule 6

PROPENTOFYLLINE

Schedule 4

PROPERIDINE

Schedule 9

PROPETAMPHOS

Schedule 6

PROPETANDROL

Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)

PROPICONAZOLE

Schedule 6
Schedule 5

PROPINEB

Schedule 6

PROPIONIBACTERIUM ACNES

Schedule 4

PROPIONIC ACID

Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3

PROPIRAM

Schedule 8

PROPOFOL

Schedule 4

PROPOXUR

Schedule 6
Schedule 5

PROPRANOLOL

Schedule 4
Appendix G

PROPYL ACETATES

Appendix B, Part 3

n-PROPYL ALCOHOL

Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3

PROPYLENE

Schedule 7

PROPYLENE GLYCOL

Appendix B, Part 3

PROPYLENE OXIDE

Appendix J, Part 2

PROPYLHEXEDRINE

Schedule 4

PROPYLTHIOURACIL

Schedule 4

PROPYPHENAZONE

Schedule 4

PROPYZAMIDE

Schedule 5

PROQUAZONE

Schedule 4

PROQUINAZID

Schedule 6

PROSCILLARIDIN

Schedule 4

PROSTAGLANDINS

Schedule 4

PROSTIANOL

Schedule 4

PROSULFOCARB

Schedule 6

PROSULFURON

Schedule 6

PROTAMINE

Schedule 4

PROTHIOCONAZOLE

Appendix B, Part 3

PROTHIOCONAZOLE-DESCHLORO

Schedule 5

PROTHIOCONAZOLE-TRIAZOLIDINETHIONE

Schedule 5

PROTHIOFOS

Schedule 6

PROTHIONAMIDE

Schedule 4

PROTHIPENDYL

Schedule 4

PROTIRELIN

Schedule 4

PROTOVERATRINES

Schedule 4

PROTRIPTYLINE

Appendix K

PROTRIPTYLINE

Schedule 4

PROXYMETACAINE

Schedule 4

PRUCALOPRIDE

Schedule 4

PSEUDOEPHEDRINE

Schedule 4
Schedule 3

PSEUDOMONAS FLUORESCENS

Appendix B, Part 3

PSILOCYBINE

Schedule 9

PTERIDIUM spp.

Schedule 10

PULMONARIA spp.

Schedule 10

PYMETROZINE

Schedule 5

PYRACLOFOS

Schedule 6

PYRACLOSTROBIN

Schedule 5

PYRAFLUFEN-ETHYL

Schedule 5

PYRANTEL

Schedule 2

PYRASULFOTOLE

Schedule 5

PYRAZINAMIDE

Schedule 4

PYRAZOPHOS

Schedule 6

PYRETHRINS
cross reference: CHRYSANTHEMIC ACID ESTERS, CINEROLONE, JASMOLONE, PYRETHRIC ACIDS, PYRETHROLONE

Schedule 5
Schedule 2

PYRIDABEN

Schedule 6
Schedule 5

PYRIDALYL

Schedule 6

PYRIDATE

Schedule 6

PYRIDINOLCARBAMATE

Schedule 4

PYRIDOSTIGMINE

Schedule 4

PYRIDOXAL

Schedule 4

PYRIDOXAMINE

Schedule 4

PYRIDOXINE

Schedule 4

PYRIFENOX

Schedule 5

PYRIMETHAMINE

Schedule 4

PYRIMETHANIL

Appendix B, Part 3

PYRINURON

Schedule 7
Appendix J, Part 2

PYRIOFENONE

Schedule 6
Schedule 5

PYRIPROLE

Schedule 6

PYRIPROXYFEN

Appendix B, Part 3

PYRITHIOBAC SODIUM

Schedule 5

PYRITHIONE COPPER

Schedule 6

PYRITHIONE ZINC

Schedule 6
Schedule 5
Schedule 2
Appendix E, Part 2

PYROVALERONE

Schedule 4

PYROXASULFONE

Schedule 6

PYROXSULAM

Schedule 6

PYRVINIUM
cross reference: VIPRYNIUMA

Schedule 4

Q

QUASSIA

Appendix B, Part 3

QUATERNARY AMMONIUM COMPOUNDS
cross reference: BENZALKONIUM CHLORIDE, DIALKYL and DIALKOYL QUATERNARY AMMONIUM COMPOUNDS

Schedule 6
Schedule 5

QUAZEPAM

Schedule 4
Appendix D, Item 5 (Benzodiazepine derivatives)

QUETIAPINE

Schedule 4
Appendix K

QUINAGOLIDE

Schedule 4

QUINALBARBITONE
cross reference: SECOBARBITAL

Schedule 8
Appendix K

QUINAPRIL

Schedule 4

QUINBOLONE

Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)

QUINCLORAC

Schedule 5

QUINETHAZONE

Schedule 4

QUINIDINE

Schedule 4

QUININE

Schedule 7
Schedule 5
Schedule 4

QUINISOCAINE
cross reference: DIMETHISOQUINE

Schedule 4

QUINOXYFEN

Appendix B, Part 3

QUINTOZENE
cross reference: PENTACHLORONITROBENZENE

Schedule 5

QUINUPRISTIN

Schedule 4

QUIZALOFOP ETHYL
cross reference: QUIZALOFOP ETHYL (D + ISOMER)

Schedule 6

QUIZALOFOP-P-ETHYL

Schedule 6
Schedule 5

QUIZALOFOP-P-TEFURYL

Schedule 6

R

RABEPRAZOLE      

Schedule 4
Schedule 3
Appendix H

RABIES VACCINE  

Schedule 4

RACEMETHORPHAN        

Schedule 9

RACEMORAMIDE  

Schedule 8

RACEMORPHAN    

Schedule 9

RACTOPAMINE      

Schedule 5
Schedule 4

RADIOGRAPHIC CONTRAST MEDIA
cross reference: RADIOPAQUES

Appendix A

RADIOISOTOPES    

Appendix A

RALOXIFENE          

Schedule 4

RALTEGRAVIR       

Schedule 4

RALTITREXED       

Schedule 4

RAMIPRIL    

Schedule 4

RANIBIZUMAB       

Schedule 4

RANITIDINE

Schedule 4
Schedule 2
Appendix F, Part 3

RAPACURONIUM   

Schedule 4

RASAGILINE           

Schedule 4

RASBURICASE        

Schedule 4

RAUWOLFIA SERPENTINA          

Schedule 4

RAUWOLFIA VOMITORIA           

Schedule 4

RAZOXANE 

Schedule 4

REBOXETINE          

Schedule 4

RED YEAST RICE   

Schedule 4

REGORAFENIB       

Schedule 4

REMIFENTANIL     

Schedule 8

REMOXIPRIDE       

Schedule 4

REPAGLINIDE        

Schedule 4

RESERPINE  

Schedule 4

RESMETHRIN         

Schedule 6
Schedule 5

RETAPAMULIN       

Schedule 4

RETEPLASE 

Schedule 4

RETIGABINE

Schedule 4
Appendix K

RIBAVIRIN  

Schedule 4

RIDAFOROLIMUS  

Schedule 4

RIFABUTIN  

Schedule 4

RIFAMPICIN

Schedule 4

RIFAMYCIN 

Schedule 4

RIFAPENTINE         

Schedule 4

RIFAXIMIN  

Schedule 4

RILPIVIRINE           

Schedule 4

RILUZOLE   

Schedule 4

RIMEXOLONE        

Schedule 4

RIMITEROL 

Schedule 4

RIMONABANT        

Schedule 4

RIMSULFURON       

Schedule 5

RIOCIGUAT 

Schedule 4
Appendix D, Item 5
Appendix L, Part 2

RISEDRONIC ACID

Schedule 4

RISPERIDONE         

Schedule 4
Appendix K

RITODRINE 

Schedule 4

RITONAVIR

Schedule 4

RITUXIMAB

Schedule 4

RIVAROXABAN      

Schedule 4

RIVASTIGMINE      

Schedule 4

RIZATRIPTAN         

Schedule 4

ROBENACOXIB      

Schedule 4

ROBENIDINE

Schedule 5

ROFECOXIB

Schedule 4

ROFLUMILAST       

Schedule 4

ROLICYCLIDINE
cross reference: PCPY, PHP

Schedule 9

ROLITETRACYCLINE       

Schedule 4

ROMIDEPSIN           

Schedule 4

ROMIFIDINE           

Schedule 4

ROMIPLOSTIM       

Schedule 4

RONIDAZOLE         

Schedule 4

ROPINIROLE           

Schedule 4

ROPIVACAINE        

Schedule 4

ROSEMARY OIL     

Appendix B, Part 3

ROSIGLITAZONE   

Schedule 4

ROSIN
cross reference: COLOPHONY

Schedule 5

ROSOXACIN

Schedule 4

ROSUVASTATIN     

Schedule 4

ROTENONE
cross reference: CUBE

Schedule 6

ROTIGOTINE          

Schedule 4
Appendix K

ROXIBOLONE

Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)

ROXITHROMYCIN

Schedule 4

RUBELLA VACCINE

Schedule 4

RUBOXISTAURIN   

Schedule 4

RUPATADINE          

Schedule 4
Appendix K

RUXOLITINIB

Schedule 4

S

SACUBITRIL

Schedule 4

SAFLUFENACIL

Schedule 7
Schedule 5

SAFROLE

Schedule 10
Schedule 3
Appendix E, Part 2
Appendix F, Part 3

SAGE OIL
cross reference: DALMATIAN, THUJONE

Schedule 6
Appendix E, Part 2

SAGE OIL (Spanish)
cross reference: CAMPHOR

Appendix B, Part 3

SALBUTAMOL

Schedule 4
Schedule 3
Appendix F, Part 3

SALCATONIN

Schedule 4

SALICYLAMIDE
cross reference: ASPIRIN, CAFFEINE, PARACETAMOL

Schedule 4
Schedule 2
Appendix F, Part 3

SALICYLANILIDE

Schedule 5

SALICYLIC ACID
cross reference: CHOLINE SALICYLATE

Schedule 3

SALINOMYCIN

Schedule 6
Schedule 4

SALMETEROL

Schedule 4

SALVIA DIVINORUM

Schedule 9

SANDALWOOD OIL

Appendix B, Part 3,

SANTONIN

Schedule 3

SAPROPTERIN

Schedule 4

SAQUINAVIR           

Schedule 4

SASSAFRAS OIL
cross reference: SAFROLE

Schedule 6
Appendix E, Part 2
Appendix F, Part 3

SAXAGLIPTIN

Schedule 4

SCHOENOCAULON OFFICINALE
cross reference: SABADILLA

Schedule 4

SCHRADAN

Schedule 7

SCOPOLIA CARNIOLICA

Schedule 4

SEAWEED

Appendix B, Part 3

SECBUTOBARBITONE

Schedule 8
Appendix K

SEDAXANE

Schedule 5

SEEDS

Appendix A

SELAMECTIN

Schedule 5

SELECTIVE ANDROGEN RECEPTOR MODULATORS
cross reference: SARM

Schedule 4
Appendix D, Item 5

SELEGILINE

Schedule 4

SELENIUM
cross reference: BARIUM SELENATE, SELENIUM COMPOUNDS, SELENIUM ARSENIDE, SELENIUM SULFIDE

Schedule 7
Schedule 6
Schedule 4
Schedule 2
Appendix E, Part 2, Part2
Appendix F, Part 3
Appendix G

SEMDURAMICIN

Schedule 7
Schedule 6

SENECIO spp.

Schedule 10

SERELAXIN

Schedule 4

SERMORELIN

Schedule 4

SERTINDOLE

Schedule 4

SERTRALINE           

Schedule 4

SETHOXYDIM

Schedule 5

SEVELAMER           

Schedule 4

SEVOFLURANE

Schedule 4

SEX HORMONES    

Schedule 4

SIBUTRAMINE

Schedule 4

SIDURON      

Schedule 5

SILANDRONE

Schedule 4
Appendix D, Item 5 (Anabolic steroidal agent)

SILDENAFIL

Schedule 4

SILICOFLUORIDES
cross reference: BARIUM SILICOFLUORIDE, FLUORIDES, FLUOROSILICATES, HEXAFLUOROSILICATES MAGNESIUM FLUOSILICATE,

Schedule 6
Schedule 5

SILICONES

Schedule 10
Schedule 4
Appendix F, Part 3

SILVER         

Schedule 2

SILVER NITRATE
cross reference: SILVER SALTS

Schedule 6
Appendix E, Part 2

SILVER SULFADIAZINE

Schedule 4

SIMAZINE

Appendix B, Part 3

SIMEPREVIR           

Schedule 4

SIMVASTATIN

Schedule 4

SINBIOALLETHRIN           

Schedule 6
Schedule 5

SINGLE-USE TUBES

Appendix A

SIROLIMUS  

Schedule 4

SISOMICIN   

Schedule 4

SITAGLIPTIN          

Schedule 4

SITAXENTAN          

Schedule 4
Appendix D, Item 6
Appendix F, Part 3
Appendix L, Part 2

SLIMICIDES 

Appendix A

SODIUM ALUMINATE       

Schedule 6
Appendix E, Part 2
Appendix F, Part 3

SODIUM BICARBONATE  

Appendix B, Part 3

SODIUM BROMATE

Schedule 6
Appendix E, Part 2

SODIUM BROMIDE

Schedule 4

SODIUM CELLULOSE PHOSPHATE       

Schedule 4

SODIUM CHLORATE         

Schedule 5
Appendix E, Part 2
Appendix F, Part 3

SODIUM CROMOGLYCATE         

Schedule 4
Schedule 2

SODIUM DIACETATE        

Schedule 5
Appendix E, Part 2

SODIUM DICHLOROISOCYANURATE   

Appendix E, Part 2

SODIUM DODECYLBENZENE SULFONATE      

Schedule 5
Appendix E, Part 2, Part
Appendix F, Part 3

SODIUM FLUORIDE           

Appendix F, Part 3

SODIUM HYDROGEN SULFATE  

Schedule 5
Appendix E, Part 2
Appendix F, Part 3

SODIUM HYDROSULFITE

Schedule 5
Appendix F, Part 3

SODIUM HYDROXIDE
cross reference: LYE WATER

Schedule 10
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3

SODIUM LAURETH-6 CARBOXYLATE  

Schedule 5
Appendix E, Part 2
Appendix F, Part 3

LAURYL SULFATE
cross reference: SODIUM LAURYL SULPHATE, DODECYL SULFATES

Schedule 6
Appendix E, Part 2

SODIUM METABISULPHITE        

Schedule 5
Appendix E, Part 2
Appendix F, Part 3

SODIUM MORRHUATE     

Schedule 4

SODIUM NITRITE   

Schedule 7
Schedule 6
Schedule 5
Schedule 2
Appendix E, Part 2
Appendix F, Part 3

SODIUM NITROPRUSSIDE

Schedule 4

SODIUM OXYBATE

Schedule 8
Appendix D, Item 1

SODIUM PERCARBONATE           

Schedule 6
Schedule 5

SODIUM PERSULFATE      

Schedule 6
Appendix E, Part 2
Appendix F, Part 3

SODIUM PHOSPHATE       

Schedule 4
Schedule 3

SODIUM PICOSULFATE    

Schedule 3

SODIUM POLYSTYRENE SULPHONATE           

Schedule 5
Schedule 4

SODIUM PRECARBONATE

Appendix E, Part 2

SODIUM PROPIONATE     

Appendix B, Part 3

SODIUM SALICYLATE      

Schedule 4

SODIUM STANNATE          

Schedule 5,
Appendix E, Part 2

SODIUM SULFIDE

Schedule 5, Schedule 6, Appendix E, Part 2, Appendix F, Part 3

SODIUM TETRADECYLSULFATE           

Schedule 4

SODIUM TRICHLOROACETATE 

Appendix E, Part 2

SODIUMHYDROSULFITE 

Appendix E, Part 2

SOFOSBUVIR

Schedule 4

SOLASODINE          

Schedule 4

SOLIFENACIN         

Schedule 4

SOMATOSTATIN    

Schedule 4

SOMATOTROPIN EQUINE

Schedule 4

SOMATROPIN
cross reference: HUMAN GROWTH HORMONE

Schedule 4
Appendix D, Item 5
Appendix G

SONTOQUINE         

Schedule 4

SORAFENIB 

-Schedule 4

SOTALOL     

Schedule 4

SPARFLOXACIN     

Schedule 4

SPARTEINE

Schedule 4

SPECTINOMYCIN   

Schedule 4

SPINETORAM          

Schedule 5

SPINOSAD    

Schedule 5

SPIRAMYCIN           

Schedule 4

SPIRAPRIL   

Schedule 4

SPIRONOLACTONE           

Schedule 4

SPIROTETRAMAT  

Schedule 6

SPIROXAMINE        

Schedule 6

SQUILL         

Schedule 2

STANOLONE           

Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)

STANOZOLOL         

Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)

STAR ANISE OIL     

Schedule 5

STAVUDINE 

Schedule 4

STENBOLONE         

Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)

STERIC ACID          

Appendix B, Part 3

STEROID HORMONES       

Schedule 4

STILBOESTROL
cross reference: DIETHYLSTILBOESTROL

Schedule 4

STRCHNINE 

Appendix E, Part 2

STREPTODORNASE           

Schedule 4

STREPTOKINASE   

Schedule 4

STREPTOMYCIN    

Schedule 4

STRONTIUM RANELATE  

Schedule 4

STROPHANTHINS  

Schedule 4

STROPHANTHUS spp.        

Schedule 4
Appendix G

STRYCHNINE
cross reference: NUX VOMICA

Schedule 7
Schedule 4
Appendix G
Appendix J, Part 2

STRYCHNOS spp.    

Schedule 4

STYRAMATE           

Schedule 4

STYRENE
cross reference: DESIGNATED SOLVENT

Schedule 5
Appendix E, Part 2
Appendix F, Part 3
Part 1 - Interpretation

SUCCIMER   

Schedule 4

SUCRALFATE          

Appendix B, Part 3

SUFENTANIL           

Schedule 8

SUGAMMADEX       

Schedule 4

SULBACTAM           

Schedule 4

SULCOFURON         

Schedule 7
Schedule 6
Appendix E, Part 2
Appendix J, Part 2

SULCONAZOLE      

Schedule 4
Schedule 2,

SULESOMAB

Appendix B, Part 3

SULFACETAMIDE  

Schedule 5
Schedule 4
Schedule 3

SULFADIAZINE       

Schedule 5
Schedule 4

SULFADIMETHOXINE       

Schedule 4

SULFADIMIDINE    

Schedule 5
Schedule 4

SULFADOXINE        

Schedule 4

SULFAFURAZOLE  

Schedule 4

SULFAGUANIDINE 

Schedule 4

SULFAMERAZINE  

Schedule 5
Schedule 4

SULFAMETHIZOLE           

Schedule 4

SULFAMETHOXAZOLE    

Schedule 4

SULFAMETHOXYDIAZINE           

Schedule 4

SULFAMETHOXYPYRIDAZINE   

Schedule 4

SULFAMETROLE    

Schedule 4

SULFAMIC ACID    

Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3

SULFAMONOMETHOXINE           

Schedule 4

SULFAMOXOLE      

Schedule 4

SULFAPHENAZOLE           

Schedule 4

SULFAPYRIDINE    

Schedule 4

SULFAQUINOXALINE       

Schedule 4

SULFASALAZINE    

Schedule 4

SULFATHIAZOLE   

Schedule 5
Schedule 4,

SULFATROXAZOLE           

Schedule 4

SULFENTRAZONE  

Schedule 7

SULFINPYRAZONE

Schedule 4

SULFLURAMID       

Schedule 6

SULFOMETURON-METHYL         

Schedule 5

SULFOMYXIN         

Schedule 4

SULFONAMIDES
cross reference: SULFACETAMIDE, SULPHANILAMIDE

Schedule 4

SULFONMETHANE
cross reference: ALKYL SULFONALS, SULFONAL

Schedule 4

SULFOSULFURON  

Appendix B, Part 3

SULFOTEP   

Schedule 7

SULFOXAFLOR       

Schedule 6
Schedule 5

SULFURIC ACID     

Schedule 6
Appendix E, Part 2
Appendix F, Part 3

SULFURYL FLUORIDE      

Schedule 6

SULINDAC   

Schedule 4

SULPHATED POLYSACCHARIDES         

Appendix B, Part 3

SULPROFOS 

Schedule 6

SULTAMICILLIN    

Schedule 4

SULTHIAME

Schedule 4

SUMATRIPTAN       

Schedule 4

SUNITINIB   

Schedule 4

SUPROFEN   

Schedule 4

SUTILAINS   

Schedule 4

SUVOREXANT         

Schedule 4
Appendix K

SUXAMETHONIUM

Schedule 4

SUXETHONIUM      

Schedule 4

SYMPHYTUM spp.
cross reference: COMFREY

Schedule 10
Schedule 5
Appendix F, Part 3

SYNTHETIC CANNABINOMIMETICS     

Schedule 9

T

TACRINE

Schedule 4

TACROLIMUS

Schedule 4

TADALAFIL

Schedule 4

TAFLUPROST

Schedule 4

TALIGLUCERASE ALFA

Schedule 4

TALLOW ALKYLAMINE ACETATES

Schedule 6

TAMOXIFEN

Schedule 4

TAMSULOSIN

Schedule 4

TANACETUM VULGARE
cross reference: OIL OF TANSY, TANSY OIL

Schedule 4

TANNIC ACID

Appendix B, Part 3

TANNIC ACID/BENZYL ALCOHOL

Appendix B, Part 3

TAPENTADOL

Schedule 8
Appendix K

TAR ACIDS

Schedule 6

TASONERMIN

Schedule 4

TAZAROTENE

Schedule 4
Appendix F, Part 3

TAZOBACTAM

Schedule 4

T-CELL RECEPTOR ANTIBODY

Schedule 4

TCMTB
cross reference: 2-[THIOCYANOMETHYLTHIO]BENZOTHIAZOLE

Schedule 6

TDE
cross reference: 1,1-DICHLORO-2,2-BIS[4-CHLOROPHENYL]ETHANE

Schedule 6
Schedule5

TEBUCONAZOLE
cross reference: TERBUCONAZOLE

Schedule 5

TEBUFENOZIDE     

Schedule 5

TEBUFENPYRAD

Schedule 6

TEBUTHIURON

Schedule 6

TEFLUTHRIN

Schedule 7
Schedule 5

TEGAFUR     

Schedule 4

TEGASEROD

Schedule 4

TEICOPLANIN

Schedule 4

TELAPREVIR

Schedule 4

TELBIVUDINE

Schedule 4

TELITHROMYCIN

Schedule 4

TELMISARTAN       

Schedule 4

TEMAZEPAM

Schedule 4
Appendix D, Item 5 (Benzodiazepine derivatives)

TEMEPHOS

Schedule 6
Schedule 5

TEMOZOLOMIDE

Schedule 4

TEMSIROLIMUS

Schedule 4

TENECTEPLASE

Schedule 4

TENIPOSIDE

Schedule 4

TENOCYCLIDINE
cross reference: TCP

Schedule 9

TENOFOVIR

Schedule 4

TENOXICAM

Schedule 4

TEPOXALIN 

Schedule 4

TEPP

Schedule 8

TEPRALOXYDIM

Schedule 5

TERAZOSIN

Schedule 4

TERBACIL

Appendix B, Part 3,Part 3

TERBINAFINE

Schedule 4
Schedule 2

TERBUFOS   

Schedule 7

TERBUTALINE

Schedule 4
Schedule 3
Appendix F, Part 3

TERBUTHYLAZINE

Schedule 6

TERBUTRYN           

Schedule 5

TERFENADINE

Schedule 4
Appendix F, Part 3

TERIFLUNOMIDE

Schedule 4
Appendix F, Part 3
Appendix L, Part 2

TERIPARATIDE

Schedule 4
Appendix D, Item 1

TERLIPRESSIN

Schedule 4

TERMITE BARRIERS

Appendix A

TERODILINE           

Schedule 4

TEROPTERIN

Schedule 4

TERPENES, CHLORINATED
cross reference: CHLORINATED TERPENES

Schedule 6
Appendix E, Part 2
Appendix F, Part 3

TESTOLACTONE

Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)

TESTOSTERONE

Schedule 6
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
Appendix G

TETANUS ANTITOXIN

Schedule 4

TETANUS TOXOID

Schedule 4

TETRABENAZINE

Schedule 4

TETRACHLOROETHANE 

Schedule 7
Appendix E, Part 2
Appendix F, Part 3
Appendix J, Part 2

TETRACHLOROETHYLENE
cross reference: DESIGNATED SOLVENT

Schedule 6
Schedule 5
Schedule 2
Appendix E, Part 2
Appendix F, Part 3
Part 1 - Interpretation

TETRACHLORVINPHOS

Schedule 5

TETRACONAZOLE

Schedule 6
Schedule 5

TETRACOSACTRIN

Schedule 4

TETRACYCLINE

Schedule 5
Schedule 4

TETRADIFON

Schedule 6

TETRAETHYLAMMONIUM

Schedule 4

TETRAHYDROCANNABINOLS
cross reference: CANNABIS, CANNABIS SATIVA, HEMP SEED OIL

Schedule 9

TETRAHYDROZOLINE

Schedule 2
Appendix F, Part 3

TETRAMETHRIN

Schedule 5

TETRAMISOLE

Schedule 6

TETROXOPRIM      

Schedule 4

THALIDOMIDE

Schedule 4
Appendix D, Item 2
Appendix F, Part 3
Appendix L, Part 2

THALLIUM
cross reference: THALLIUM SULFATE

Schedule 7
Appendix J, Part 2

THAUMATIN

Appendix B, Part 3

THEBACON 

Schedule 8

THEBAINE

Schedule 8

THENYLDIAMINE

Schedule 4
Appendix K     Schedule 4, Appendix K

THEOPHYLLINE

Schedule 4
Schedule 3

THEVETIA PERUVIANA

Schedule 4

THEVETIN   

Schedule 4

THIABENDAZOLE

Schedule 5
Schedule 2

THIACETARSAMIDE

Schedule 4

THIACLOPRID

Schedule 6

THIAMBUTOSINE

Schedule 4

THIAMETHOXAM

Schedule 6
Schedule 5

THIAZAFLURON

Schedule 6

THIAZOPYR

Schedule 5

THIAZOSULFONE  

Schedule 4

THIDIAZURON

Appendix B, Part 3

THIETHYLPERAZINE

Schedule 4
Appendix K

THIFENSULFURON

Schedule 5

THIOACETAZONE

Schedule 4

THIOBENCARB       

Schedule 5

THIOCARLIDE

Schedule 4

THIODICARB

Schedule 6
Schedule 5

THIOFANOX

Schedule 7

THIOFENTANYL

Schedule 9

THIOGUANINE

Schedule 4

THIOMESTERONE
cross reference: TIOMESTERONE

Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)

THIOMETON           

Schedule 6

THIOPENTONE

Schedule 4

THIOPHANATE-METHYL

Schedule 6
Schedule 5

THIOPROPAZATE

Schedule 4
Appendix K

THIOPROPERAZINE          

Schedule 4

THIORIDAZINE

Schedule 4
Appendix K

THIOSTREPTON

Schedule 4

THIOTEPA
cross reference: TRIETHYLENE THIOPHOSPHORAMIDE

Schedule 4

THIOTHIXENE

Schedule 4
Appendix K

THIOURACIL

Schedule 4

THIOUREA
cross reference: ALKYL THIOUREAS

Schedule 6
Schedule 4
Appendix E, Part 2
Appendix F, Part 3

THIRAM

Schedule 6

THUJONE

Schedule 6
Appendix E, Part 2

THYME OIL 

Schedule 5
Appendix E, Part 2

THYMOL

Schedule 6

THYMOXAMINE

Schedule 4

THYROID

Schedule 4

THYROTROPHIN
cross reference: TSH

Schedule 4

THYROXINE

Schedule 4
Appendix G

TIAGABINE

Schedule 4

TIAMULIN

Schedule 4

TIAPROFENIC ACID          

Schedule 4

TIARAMIDE 

Schedule 4

TIBOLONE

Schedule 4

TICAGRELOR

Schedule 4

TICARCILLIN         

Schedule 4

TICLOPIDINE          

Schedule 4

TIEMONIUM

Schedule 4

TIENILIC ACID

Schedule 4

TIGECYCLINE

Schedule 4

TIGLOIDINE

Schedule 4

TILDIPIROSIN

Schedule 4

TILETAMINE           

Schedule 4

TILIDINE      

Schedule 8

TILMICOSIN

Schedule 4

TILUDRONIC ACID
cross reference: DISODIUM TILUDRONATE

Schedule 4

TIMBER
cross reference: WALLBOARD

Appendix A

TIMOLOL

Schedule 4

TIN ORGANIC COMPOUNDS
cross reference: DIALKYL TIN COMPOUNDS, DIBUTYL TIN COMPOUNDS, DIETHYL TIN COMPOUNDS, DIMETHYL TIN DICHLORIDE, DIMETHYL TIN COMPOUNDS, DIPROPYL TIN COMPOUNDS, FENBUTATIN OXIDE, ORGANO TIN-COMPOUNDS, TBTO, TRIALKYL TIN COMPOUNDS, TRIBUTYL TIN COMPOUNDS, TRIETHYL TIN COMPOUNDS, TRIMETHYL TIN COMPOUNDS, TRIPHENYL TIN COMPOUNDS, TRIPROPYL TIN COMPOUNDS

Schedule 7

TINIDAZOLE           

Schedule 4

TINZAPARIN

Schedule 4

TIOCARBAZIL

Schedule 5

TIOCONAZOLE

Schedule 4
Schedule 3
Schedule 2

TIOTROPIUM

Schedule 4

TIPEPIDINE 

Schedule 4

TIPRANAVIR           

Schedule 4

TIRILAZAD

Schedule 4

TIROFIBAN

Schedule 4

TOBRAMYCIN

Schedule 4

TOCAINIDE

Schedule 4

TOCERANIB

Schedule 4

TOCILIZUMAB

Schedule 4

TOLAZAMIDE

Schedule 4

TOLAZOLINE

Schedule 4

TOLBUTAMIDE

Schedule 4

TOLCAPONE

Schedule 4

TOLCLOFOS-METHYL

Schedule 5

TOLFENAMIC ACID          

Schedule 4

TOLIDINE

Schedule 4
Appendix E, Part 2

TOLMETIN

Schedule 4

TOLONIUM

Schedule 4

TOLPROPAMINE

Schedule 4

TOLRESTAT

Schedule 4

TOLTERODINE

Schedule 4

TOLTRAZURIL

Schedule 5

TOLUENE
cross reference: XYLENE

Schedule 6
Appendix E, Part 2
Appendix F, Part 3

TOLUENEDIAMINES

Schedule 10
Schedule 6
Appendix E, Part 2
Appendix F, Part 3

TOLVAPTAN

Schedule 4

TOLYLFLUANID

Schedule 6

TOPIRAMATE

Schedule 4

TOPOTECAN           

Schedule 4

TORASEMIDE

Schedule 4

TOREMIFENE

Schedule 4

TOXOIDS      

Schedule 4

TRALKOXYDIM

Schedule 5

TRAMADOL 

Schedule 4
Appendix K

TRAMAZOLINE

Schedule 2
Appendix F, Part 3

TRAMETINIB DIMETHYL SULFOXIDE 

Schedule 4

TRANDOLAPRIL

Schedule 4

TRANEXAMIC ACID          
cross reference: CETYL TRANEXAMATE

Schedule 4

TRANSFLUTHRIN  

Schedule 6

TRANYLCYPROMINE

Schedule 4
Appendix K

TRASTUZUMAB      

Schedule 4

TRASTUZUMAB EMTANSINE

Schedule 4

TRAVOPROST

Schedule 4

TRAZODONE           

Schedule 4

TRENBOLONE
cross reference: TRIENBOLONE, TRIENOLONE

Schedule 5
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)

TREOSULPHAN

Schedule 4

TREPROSTINIL

Schedule 4

TRESTOLONE

Schedule 4
Appendix D, Item 5 (androgenic steroidal agents)

TRETAMINE

Schedule 4

TRETINOIN 

Schedule 4
Appendix D, Item 4
Appendix F, Part 3
Appendix L, Part 2

TRIACETYLOLEANDOMYCIN

Schedule 4

TRIADIMEFON

Schedule 6
Schedule 5

TRIADIMENOL

Schedule 5

TRI-ALLATE

Schedule 5

TRIAMCINOLONE 

Schedule 4
Schedule 3
Schedule 2
Appendix F, Part 3, Part 2

TRIAMIPHOS

Schedule 7

TRIAMTERENE

Schedule 4

TRIASULFURON

Appendix B, Part 3

TRIAZBUTIL           

Schedule 7

TRIAZIQUONE

Schedule 4

TRIAZOLAM           

Schedule 4
Appendix D, Item 5 (benzodiazepine derivatives)

TRIBENURON-METHYL   

Schedule 5

TRIBUFOS
cross reference: s,s,s-TRIBUTYLPHOSPHOROTRITHIOATE

Schedule 7

TRICHLORFON
cross reference: METRIFONATE

Schedule 6

TRICHLORMETHIAZIDE

Schedule 4

TRICHLOROACETIC ACID          

Schedule 6
Schedule 5
Schedule 4
Appendix E, Part 2
Appendix F, Part 3

TRICHLOROACETIC ACID ALKALI SALTS

Schedule 5
Appendix E, Part 2

TRICHLOROETHYLENE
cross reference: TRICHLOROETHENE

Schedule 6
Schedule 4
Appendix E, Part 2
Appendix F, Part 3

TRICHLOROPHENOL

Schedule 6
Appendix F, Part 3

TRICHODERMA HARZIANUM

Appendix B, Part 3

TRICHODESMA AFRICANA

Schedule 10

TRICLABENDAZOLE

Schedule 6

TRICLOFOS

Schedule 4

TRICLOPYR

Schedule 6

TRICLOSAN

Schedule 6

TRICYCLAMOL

Schedule 4

TRIDEMORPH         

Schedule 6

TRIDIHEXETHYL

Schedule 4

TRIDIPHANE

Schedule 5

TRIETAZINE

Schedule 5

TRIETHANOLAMINE

Schedule 5
Schedule 4
Appendix E, Part 2
Appendix F, Part 3

TRIETHYL PHOSPHATE

Schedule 6
Appendix E, Part 2

TRIETHYLENE GLYCOL

Appendix B, Part 3

TRIFLOXYSTROBIN

Schedule 5

TRIFLOXYSULFURON      

Appendix B, Part 3

TRIFLUMIZOLE

Schedule 5

TRIFLUMURON      

Schedule 5

TRIFLUOPERAZINE

Schedule4
Appendix K

TRIFLUOROMETHANESULFONIC ACID

Schedule 6
Appendix E, Part 2
Appendix F, Part 3

TRIFLUPERIDOL

Schedule 4

TRIFLUPROMAZINE

Schedule 4

TRIFLURALIN

Appendix B, Part 3

TRIFORINE

Appendix B, Part 3

TRIISOPROPANOLAMINE LAURYL ETHER SULFATE

Schedule 5
Appendix E, Part 2
Appendix F, Part 3

TRILOSTANE

Schedule 4

TRIMEPRAZINE

Schedule 4
Schedule 3
Schedule 2
Appendix K

TRIMETAPHAN

Schedule 4

TRIMETHOPRIM

Schedule 4

TRIMIPRAMINE

Schedule 4
Appendix K

TRIMUSTINE           

Schedule 4

TRINEXAPAC-ETHYL

Schedule 5

TRINITROPHENOL

Schedule 6
Schedule 4

TRIOXYSALEN

Schedule 4

TRIPARANOL

Schedule 10

TRIPELENNAMINE

Schedule 4

TRIPLE ANTIGEN VACCINE

Schedule 4

TRIPROLIDINE

Schedule 4
Schedule 3
Schedule 2
Appendix K

TRIPTORELIN

Schedule 4

TRISODIUM NITRILOTRIACETATE

Schedule 6

TRITICONAZOLE

Schedule 5

TROGLITAZONE

Schedule 4

TROMETAMOL

Schedule 4

TROPICAMIDE

Schedule 4

TROPISETRON

Schedule 4

TROVAFLOXACIN

Schedule 4

TROXIDONE

Schedule 4

TRYPTOPHAN

Schedule 4

TUAMINOHEPTANE

Schedule 2

TUBERCULIN

Schedule 4

TUBOCURARINE    

Schedule 4

TULATHROMYCIN

Schedule 4

TULOBUTEROL

Schedule 4

TURPENTINE OIL
cross reference: OIL OF TURPENTINE

Schedule 5
Appendix E, Part 2

TUSSILAGO FARFARA
cross reference: COLTSFOOT

Schedule 10

TYLOSIN

Schedule 4

TYMAZOLINE

Schedule 4
Appendix F, Part 3

TYPHOID VACCINE           

Schedule 4

U

ULOCLADIUM OUDEMANSII

Appendix B, Part 3

UMECLIDINIUM

Schedule 4

UNOPROSTONE

Schedule 4

URACIL

Schedule 4

URAPIDIL

Schedule 4

UREA

Appendix B, Part 3

URETHANE

Schedule 4

UROFOLLITROPIN
cross reference: FOLLICLE-STIMULATING HORMONE, HUMAN

Schedule 4
Appendix D, Item 1

UROKINASE

Schedule 4

URSODEOXYCHOLIC ACID

Schedule 4

USTEKINUMAB

Schedule 4

V

VACCINES

Schedule 4

VACCINIA VIRUS VACCINE

Schedule 4

VALACICLOVIR

Schedule 4

VALDECOXIB

Schedule 4

VALGANCICLOVIR

Schedule 4

VALNOCTAMIDE

Schedule 4

VALPROIC ACID

Schedule 4

VALSARTAN

Schedule 4

VAMIDOTHION

Schedule 6

VANCOMYCIN

Schedule 4

VANDETANIB

Schedule 4

VARDENAFIL

Schedule 4

VARENICLINE

Schedule 4

VARICELLA VACCINE

Schedule 4

VASOPRESSIN

Schedule 4

VECURONIUM

Schedule 4

VEDAPROFEN

Schedule 4

VEDOLIZUMAB

Schedule 4

VELAGLUCERASE ALFA

Schedule 4

VEMURAFENIB       

Schedule 4

VENLAFAXINE

Schedule 4

VERAPAMIL

Schedule 4

VERATRUM 

Schedule 4

VERNAKALANT

Schedule 4

VERNOLATE

Schedule 5

VERTEPORFIN

Schedule 4

VETIVER OIL

Appendix B, Part 3

VIDARABINE           

Schedule 4

VIGABATRIN          

Schedule 4

VILANTEROL

Schedule 4

VILDAGLIPTIN

Schedule 4

VILOXAZINE

Schedule 4

VINBLASTINE

Schedule 4

VINCAMINE

Schedule 4

VINCLOZOLIN

Schedule 6
Appendix F, Part 3

VINCRISTINE

Schedule 4

VINDESINE  

Schedule 4

VINFLUNINE

Schedule 4

VINORELBINE

Schedule 4

VINYL CHLORIDE

Schedule 7
Appendix J, Part 2

VINYL ETHER

Schedule 4

VIRGINIAMYCIN   

Schedule 5
Schedule 4

VISMODEGIB

Schedule 4

VISNADINE  

Schedule 4

VITAMIN A

Schedule 4

VITAMIN D
cross reference: COLECALCIFEROL, ERGOCACIFEROL

Schedule 4
Schedule 3

VITAMIN K
cross reference: PHYTOMENADIONE

Appendix B, Part 3

VITREOUS ENAMELS        

Appendix A

VORICONAZOLE

Schedule 4

VORINOSTAT

Schedule 4

VORTIOXETINE

Schedule 4

W

WALLBOARD
cross reference: TIMBER

Appendix A

WARFARIN  

Schedule 6
Schedule 5
Schedule 4

WRITING CORRECTION PENS

Appendix A

X

XAMOTEROL

Schedule 4

XANTHINOL NICOTINATE          

Schedule 4

XANTHOPHYLL
cross reference: LUTEIN

Appendix B, Part 3

XIMELAGATRAN   

Schedule 4

XIPAMIDE

Schedule 4

XYLANASE derived from Aspergillus niger

Appendix B, Part 3

XYLAZINE   

Schedule 4

XYLENE
cross reference: TOLUENE

Schedule 6
Appendix E, Part 2
Appendix F, Part 3

XYLOMETAZOLINE          

Schedule 2
Appendix F, Part 3

Y

YLANG YLANG OIL

Appendix B, Part 3

YOHIMBINE
cross reference: ASPIDOSPERMA QUEBRACHO

Schedule 4

Z

(Z)-9-TRICOSENE
cross reference: TRICOSENE

Appendix B, Part 3

ZAFIRLUKAST

Schedule 4

ZALCITABINE

Schedule 4

ZALEPLON

Schedule 4

ZANAMIVIR

Schedule 4

ZERANOL

Schedule 6
Schedule4

ZETA-CYPERMETHRIN    

Schedule 7
Schedule 6

ZIDOVUDINE

Schedule 4

ZILPATEROL

Schedule 4

ZIMELDINE

Schedule 4

ZINC BORATE

Schedule 6

ZINC CHLORIDE

Schedule4
Appendix E, Part 2

ZINC COMPOUNDS

Schedule 4

ZINC LACTATE

Schedule 6
Appendix F, Part 3

ZINC NAPHTHENATE

Appendix B, Part 3

ZINC para-PHENOLSULFONATE 

Schedule 6

ZINC SULFATE

Schedule 6
Appendix E, Part 2
Appendix F, Part 3

ZINEB
cross reference: DITHIOCARBAMATES, MANCOZEB, PROPINEB, THIRAM

Schedule 5

ZIPRASIDONE

Schedule 4
Appendix K

ZIRAM

Schedule 7
Schedule 6

ZOLAZEPAM           

Schedule 4

ZOLEDRONIC ACID          

Schedule 4

ZOLMITRIPTAN

Schedule 4

ZOLPIDEM

Schedule4
Appendix K

ZONISAMIDE

Schedule 4
Appendix K

ZOPICLONE

Schedule 4
Appendix K

ZOXAZOLAMINE

Schedule 4

ZUCLOPENTHIXOL           

Schedule 4